Document:

exv10w1

Exhibit 10.1

SUBSCRIPTION AGREEMENT

Idera Pharmaceuticals, Inc.

167 Sidney Street

Cambridge, MA 02139

Gentlemen:

The undersigned (the “Investor”) hereby confirms its agreement with you as follows:

     This Subscription Agreement, including the Terms and Conditions for Purchase of Units attached
hereto as Annex I (collectively, this “Agreement”) is made as of the date set forth
below between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the
Investor.

     The Company has authorized the sale and issuance to the Investor of up to an aggregate of
4,071,005 units (the “Units”), each consisting of (i) one share (the “Share,”
collectively the “Shares”) of its common stock, par value $0.001 per share (the “Common
Stock”), and (ii) one warrant (the “Warrant,” collectively the “Warrants”) to
purchase .40 of a share of Common Stock (the fractional amount being the “Warrant Ratio”),
for a purchase price of $3.71 per Unit (the “Purchase Price”). The initial exercise price
of the Warrant is $3.71 per whole share. The shares of Common Stock issuable upon the exercise of
the Warrants are referred to herein as the “Warrant Shares.” The Warrants are exercisable
beginning on the date of the Closing (as defined below), and have a term of exercise of five years.
The Warrant Shares, together with the Shares and the Warrants, are referred to herein as the
“Securities”. The form of Warrant is attached hereto as Exhibit A.

     The offering and sale of the Units (the “Offering”) are being made pursuant to (1) an
effective Registration Statement on Form S-3 (including the Prospectus contained therein (the
“Base Prospectus”), the “Registration Statement”) filed by the Company with the
Securities and Exchange Commission (the “Commission”), (2) if applicable, certain “free
writing prospectuses” (as that term is defined in Rule 405 under the Securities Act of 1933, as
amended (the “Act”)), that have been or will be filed with the Commission and delivered to
the Investor on or prior to the date hereof, and (3) a Prospectus Supplement (the “Prospectus
Supplement” and together with the Base Prospectus, the “Prospectus”) containing certain
supplemental information regarding the Securities and terms of the Offering that will be filed with
the Commission and delivered to the Investor (or made available to the Investor by the filing by
the Company of an electronic version thereof with the Commission) no later than two (2) days
subsequent to the execution of this Agreement.

     The Company and the Investor agree that the Investor will purchase from the Company and the
Company will issue and sell to the Investor the Units set forth below for the aggregate Purchase
Price set forth below. The Units shall be purchased pursuant to the Terms and Conditions for
Purchase of Units attached hereto as Annex I and incorporated herein by this reference as
if fully set forth herein. The Investor acknowledges that the Offering is not being underwritten by
the placement agent (the “Placement Agent”) named in the Prospectus Supplement and that
there is no minimum offering amount.

     The Investor represents that, except as set forth below, (a) it has had no position, office or
other material relationship within the past three years with the Company or persons known to it to
be affiliates of the Company, (b) it is not a FINRA member or an Associated Person of any FINRA
member (as defined in FINRA Membership and Registration Rules Section 1011) as of the Closing (as
defined in Annex I), and (c) neither the Investor nor any group of Investors (as identified
in a public filing made

 

 

with the Commission) of which the Investor is a part in connection with the Offering of the
Units, has acquired, or has obtained the right to acquire, 20% or more of the Common Stock (or
securities convertible into or exercisable for Common Stock) or the voting power of the Company on
a post-transaction basis. Exceptions:

 

(If no exceptions, write “none.” If left blank, response will be deemed to be “none.”)

     The completion of the purchase and sale of the Securities shall occur at a closing (the
“Closing”) which, in accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of
1934, as amended, is expected to occur on or about August 5, 2010. At the Closing, (a) the Company
shall cause its transfer agent to release to the Investor the number of Shares being purchased by
the Investor, (b) the Company shall deliver to the Investor the Warrants being purchased by the
Investor by physical delivery and (c) the aggregate purchase price for the Securities being
purchased by the Investor will be released from the escrow account established for the Closing. The
Investor shall settle the Shares via Deposit/Withdrawal At Custodian (“DWAC”) and the provisions
set forth in Exhibit B hereto shall be incorporated herein by reference as if set forth fully
herein, provided, however, if requested by the Investor, settlement shall be via delivery versus
payment (“DVP”), pursuant to the DVP instructions previously provided to the Investor by the
Company.

     The Investor represents that it has received (or otherwise can obtain on the Commission’s
EDGAR filing system) the Base Prospectus, dated August 31, 2007, which is a part of the Company’s
Registration Statement, the documents incorporated by reference therein, and any free writing
prospectus (collectively, the “Disclosure Package”), prior to or in connection with the
receipt of this Agreement.

     No offer by the Investor to buy Units will be accepted and no part of the Purchase Price will
be delivered to the Company until the Company has accepted such offer by countersigning a copy of
this Agreement, and any such offer may be withdrawn or revoked, without obligation or commitment of
any kind, at any time prior to the Company (or the Placement Agent on behalf of the Company)
sending (orally, in writing or by electronic mail) notice of its acceptance of such offer. An
indication of interest will involve no obligation or commitment of any kind until this Agreement is
accepted and countersigned by or on behalf of the Company.

[Remainder of the page intentionally left blank.]

-2-

 

Number of Units:                     

Purchase Price Per Unit: $______

Aggregate Purchase Price: $______

Please check (A) or (B) below:

      (A) Investor elects to have 4.99% Maximum Percentage Beneficial Ownership

Limitation in its Warrant: (check here) ______

Or

     
(B) Investor elects to have no Beneficial Ownership

Limitation
in its Warrant (Section 2(e) of the Warrant will be excluded):
(check here) ______

Please confirm that the foregoing correctly sets forth the agreement between us by signing in the
space provided below for that purpose.

	 	 	 	 	 
	 	Dated as of: August 2, 2010

 	 
	 	
INVESTOR

 	 
	 	By:  	 	 
	 	 	Print Name:  	  	 
	 	 	Title:  	 	 
	 	 	Address:  	 	 
	 	 	  	 	 
	 	 	Email:  	 	 
	 

[INVESTOR SIGNATURE PAGE TO IDERA SUBSCRIPTION AGREEMENT]

-3-

 

	 	 	 	 	 
	Agreed and Accepted

as of August 2, 2010:

IDERA PHARMACEUTICALS, INC.

 	 	 
	By:  	 	 	 
	 	Name:  	 	 	 
	 	Title:  	 	 	 
	 

[COMPANY SIGNATURE PAGE TO IDERA SUBSCRIPTION AGREEMENT]

-4-

 

ANNEX I

TERMS AND CONDITIONS FOR PURCHASE OF UNITS

     Authorization and Sale of the Units. Subject to the terms and conditions of this Agreement,
the Company has authorized the sale of the Units, which consist of the Shares and the Warrants.

     Agreement to Sell and Purchase the Units; Placement Agent.

          At the Closing (as defined in Section 3.1), the Company will sell to the Investor, and
the Investor will purchase from the Company, upon the terms and conditions set forth herein, the
number of Units set forth on the last page of the Agreement to which these Terms and Conditions for
Purchase of Units are attached as Annex I (the “Signature Page”) for the aggregate
Purchase Price therefor set forth on the Signature Page.

          The Company may enter into agreements similar to this Agreement with other investors (the
“Other Investors”) and expects to complete sales of the Units to them. (The Investor and
the Other Investors are hereinafter referred to as the “Investors” and this Agreement and
the agreements executed by the Other Investors are hereinafter collectively referred to as the
“Agreements”). The Company may accept or reject any one or more Agreements in its sole
discretion.

          The Company has entered into a Placement Agency Agreement, dated on or about August 2, 2010
(the “Placement Agreement”), with Rodman & Renshaw, LLC (the “Placement Agent”)
that contains certain representations, warranties, covenants and agreements of the Company that may
be relied upon by the Investor, which shall be a third party beneficiary thereof. Investor
acknowledges that the Company has agreed to pay the Placement Agent a fee (the “Placement
Fee”) in respect of the sale of Units to the Investor.

     Closings and Delivery of the Units and Funds.

          Closing. The completion of the purchase and sale of the Units (the “Closing”)
shall occur at a place and time (the “Closing Date”) and in the manner specified by the
Company and the Placement Agent as provided in the Placement Agreement, and of which the Investor
will be notified in advance by the Placement Agent, in accordance with Rule 15c6-1 promulgated
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). At the
Closing, (a) the Company shall cause its transfer agent to deliver to the Investor the number of
Shares set forth on the Signature Page registered in the name of the Investor or, if so indicated
on the Investor Questionnaire attached hereto as Exhibit B, in the name of a nominee
designated by the Investor and (b) the Company shall cause to be delivered to the Investor a
warrant to purchase a number of whole Warrant Shares determined by multiplying the Number of Shares
(and Units) set forth on the signature page by the Warrant Ratio and rounding down to the nearest
whole number, and (c) the aggregate purchase price for the Units being purchased by the Investor
will be released from the escrow account established for the Closing.

          Conditions to the Company’s Obligations. The Company’s obligation to issue and sell
the Units to the Investor shall be subject to: (i) the receipt by the Company of the Purchase Price
for the Units being purchased hereunder as set forth on the Signature Page, (ii) an executed Form
W-9 and (iii) the accuracy of the representations and warranties made by the Investor and the
fulfillment of those undertakings of the Investor to be fulfilled prior to the Closing Date.

          Conditions to the Investor’s Obligations. The Investor’s obligation to purchase the
Units will be subject to the condition that the Placement Agent shall not have: (a) terminated the

1

 

Placement Agreement pursuant to the terms thereof or (b) determined that the conditions to the
Closing as set forth in the Placement Agreement have not been satisfied. The Investor’s
obligations are expressly not conditioned on the purchase by any or all of the Other Investors of
the Units that they have agreed to purchase from the Company or the issuance of any minimum amount
of Units by the Company.

          Delivery of Funds and Units. The Investor shall settle the Shares via
Deposit/Withdrawal At Custodian (“DWAC”) and the provisions set forth in Exhibit B hereto
shall be incorporated herein by reference as if set forth fully herein, and the Warrants via
physical delivery, and simultaneously therewith or prior thereto, payment shall be made by the
Investor to the escrow account designated by the Company, provided, however, if requested by the
Investor, settlement shall be via delivery versus payment (“DVP”), pursuant to the DVP instructions
previously provided to the Investor by the Company.

     Representations, Warranties and Covenants of the Investor.

     The Investor acknowledges, represents and warrants to, and agrees with, the Company and the
Placement Agent that:

          The Investor (a) is knowledgeable, sophisticated and experienced in making, and is qualified
to make decisions with respect to, investments in securities presenting an investment decision like
that involved in the purchase of the Units, including investments in securities issued by the
Company and investments in comparable companies, (b) has answered all questions on the Signature
Page and the Investor Questionnaire and the answers thereto are true and correct as of the date
hereof and will be true and correct as of the Closing Date and (c) in connection with its decision
to purchase the number of Units set forth on the Signature Page, has received and is relying only
upon the Disclosure Package. Other than the issuance of the Units as described in Section 1 of this
Agreement, the Investor acknowledges that it has not received from the Company any information that
the Company has advised the Investor that it deems to be material or non-public concerning the
Company.

          (a) No action has been or will be taken in any jurisdiction outside the United States by the
Company or the Placement Agent that would permit an offering of the Securities, or possession or
distribution of offering materials in connection with the issue of the Securities in any
jurisdiction outside the United States where action for that purpose is required, (b) if the
Investor is outside the United States, it will comply with all applicable laws and regulations in
each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its
possession or distributes any offering material, in all cases at its own expense and (c) the
Placement Agent is not authorized to make and has not made any representation, disclosure or use of
any information in connection with the issue, placement, purchase and sale of the Units, except as
set forth or incorporated by reference in the Disclosure Package.

          (a) The Investor has full right, power, authority and capacity to enter into this Agreement
and to consummate the transactions contemplated hereby and has taken all necessary action to
authorize the execution, delivery and performance of this Agreement, and (b) this Agreement
constitutes a valid and binding obligation of the Investor enforceable against the Investor in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting
parties’ rights generally and except as enforceability may be subject to general principles of
equity (regardless of whether such enforceability is considered in a proceeding in equity or at
law) and except as to the enforceability of any rights to indemnification or contribution that may
be violative of the public policy underlying any law, rule or regulation (including any federal or
state securities law, rule or regulation).

2

 

          The Investor understands that nothing in this Agreement, the Base Prospectus, the Prospectus
Supplement or any other materials presented to the Investor in connection with the purchase and
sale of the Units constitutes legal, tax or investment advice. The Investor has consulted such
legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or
appropriate in connection with its purchase of Units.

          Since the date on which a Placement Agent first contacted the Investor about the Offering, the
Investor has kept the Offering confidential and has not engaged in any purchases or sales of the
securities of the Company (including, without limitation, any Short Sales involving the Company’s
securities). The Investor covenants that it will keep the Offering confidential and not engage in
any purchases or sales of the securities of the Company (including Short Sales) prior to the time
that the transactions contemplated by this Agreement are publicly disclosed. Each Investor agrees
that it will not use any of the Securities acquired pursuant to this Agreement to cover any short
position in the Common Stock if doing so would be in violation of applicable securities laws. For
purposes hereof, “Short Sales” include, without limitation, all “short sales” as
defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against
the box, and all types of direct and indirect stock pledges, forward sales contracts, options,
puts, calls, short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h)
under the Exchange Act) and similar arrangements (including on a total return basis), and sales and
other transactions through non-US broker dealers or foreign regulated brokers.

     Survival of Representations, Warranties and Agreements; Third Party Beneficiary.
Notwithstanding any investigation made by any party to this Agreement or by the Placement Agent,
all covenants, agreements, representations and warranties made by the Company and the Investor
herein will survive the execution of this Agreement, the delivery to the Investor of the Units
being purchased and the payment therefor. The Placement Agent shall be a third party beneficiary
with respect to the representations, warranties and agreements of the Investor in Section 4 hereof.

     Notices. All notices, requests, consents and other communications hereunder will be in
writing, will be mailed (a) if within the domestic United States by first-class registered or
certified airmail, or nationally recognized overnight express courier, postage prepaid, or by
facsimile or (b) if delivered from outside the United States, by International Federal Express or
facsimile, and will be deemed given (i) if delivered by first-class registered or certified mail
domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight
carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two
business days after so mailed and (iv) if delivered by facsimile, upon electronic confirmation of
receipt and will be delivered and addressed as follows:

	if to the Company, to :

Idera Pharmaceuticals, Inc.

167 Sidney Street

Cambridge, MA 02139

Attention: Chief Financial Officer

Facsimile: ______________

with copies (for information purposes only) to :

Wilmer Cutler Pickering Hale and Dorr LLP

60 State Street

Boston, MA 02109

Attention: Stuart M. Falber, Esq.

Facsimile: (617) 526-5000

3

 

If to the Investor: at its address on the Signature Page hereto, or at such other address or
addresses as may have been furnished to the Company in writing, with copies (for informational
purposes only) to the person(s) identified on the Signature Page hereto.

     Changes. This Agreement may not be modified or amended except pursuant to an instrument in
writing signed by the Company and the Investor.

     Headings. The headings of the various sections of this Agreement have been inserted for
convenience of reference only and will not be deemed to be part of this Agreement.

     Severability. In case any provision contained in this Agreement should be invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions
contained herein will not in any way be affected or impaired thereby.

     Governing Law. This Agreement will be governed by, and construed in accordance with, the
internal laws of the State of New York, without giving effect to the principles of conflicts of law
that would require the application of the laws of any other jurisdiction.

     Counterparts. This Agreement may be executed in two or more counterparts, each of which will
constitute an original, but all of which, when taken together, will constitute but one instrument,
and will become effective when one or more counterparts have been signed by each party hereto and
delivered to the other parties.

     Confirmation of Sale. The Investor acknowledges and agrees that the Investor’s receipt of the
Company’s counterpart to this Agreement, together with the Prospectus Supplement (or the filing by
the Company of an electronic version thereof with the Commission), shall constitute written
confirmation of the Company’s sale of Units to the Investor.

     Press Release. The Company and the Investor agree that the Company shall issue a press release
announcing the material terms of the Offering prior to the opening of the financial markets in New
York City on the business day immediately after the date hereof to the extent permitted by
applicable law and the rules and regulations of the Commission.

     Termination. In the event that the Placement Agreement is terminated by the Placement Agent
pursuant to the terms thereof, this Agreement shall terminate without any further action on the
part of the parties hereto.

4

 

Exhibit A

Form of Warrant

COMMON STOCK PURCHASE WARRANT

IDERA PHARMACEUTICALS, INC.

			
	 	 	 
	Warrant Shares: ______
	 	Initial Exercise Date: August ___, 2010

     THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received,
______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the
limitations on exercise and the conditions hereinafter set forth, at any time on or after the date
hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five
year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter,
to subscribe for and purchase from Idera Pharmaceuticals, Inc., a Delaware corporation (the
“Company”), up to ___ shares (as subject to adjustment hereunder, the “Warrant
Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).

     Section 1. Definitions. Capitalized terms used and not otherwise defined
herein shall have the meanings set forth in those certain Subscription Agreements (the
“Purchase Agreement”), dated August 2, 2010, between the Company and the purchasers
signatory thereto.

Section 2. Exercise.

     a) Exercise of the purchase rights represented by this Warrant may be made, in whole or
in part, at any time or times on or after the Initial Exercise Date and on or before the
Termination Date by delivery to the Company (or such other office or agency of the Company
as it may designate by notice in writing to the registered Holder at the address of the
Holder appearing on the books of the Company) of a duly executed facsimile copy of the
Notice of Exercise Form annexed hereto. Within three (3) Trading Days following the date of
exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price (as defined
below) for the shares specified in the applicable Notice of Exercise by wire transfer or
cashier’s check drawn on a United States bank unless the cashless exercise procedure
specified in Section 2(c) below is specified in the applicable Notice of Exercise.
Notwithstanding anything herein to the contrary, the Holder shall not be required to
physically surrender this Warrant to the Company in order to effect an exercise hereunder
but shall deliver the original Warrant within three (3) Trading Days (as defined below)
following delivery of the Notice of Exercise. A “Trading Day” shall mean a day on
which the principal trading market on which the Common Stock is listed or quoted for trading
is open for trading. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The
Company shall deliver any objection to any Notice of Exercise Form within one (1) Business
Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the
purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares

1

 

available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.

     b) Exercise Price. The exercise price per share of the Common Stock under this
Warrant shall be $3.71, subject to adjustment hereunder (the “Exercise Price”).

     c) Cashless Exercise. If at the time of exercise hereof there is no effective
registration statement registering, or the prospectus contained therein is not available for
the issuance of the Warrant Shares to the Holder and all of the Warrant Shares are not then
registered for resale by Holder into the market at market prices from time to time on an
effective registration statement for use on a continuous basis (or the prospectus contained
therein is not available for use), then this Warrant may also be exercised, in whole or in
part, at such time by means of a “cashless exercise” in which the Holder shall be entitled
to receive a certificate for the number of Warrant Shares equal to the quotient obtained by
dividing [(A-B) (X)] by (A), where:

	 	(A)	=  	the Fair Market Value on the Trading Day immediately
preceding the date on which Holder elects to exercise this Warrant by means of
a “cashless exercise,” as set forth in the applicable Notice of Exercise;
	 
	 	(B)	=  	the Exercise Price of this Warrant, as adjusted hereunder;
and
	 
	 	(X)	=  	the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise;

provided that, in the event that (B) is greater than (A), this Warrant may not be so
exercised by means of a cashless exercise.

     “Fair Market Value” means, for any date, the price determined by the first
of the following clauses that applies: (a) if the Common Stock is then listed or quoted on
the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, or the New York Stock Exchange (each, a “Trading Market”), the closing sales
price for the shares of Common Stock for such date (or the nearest preceding date) on the
principal Trading Market on which the Common Stock is then listed or quoted as reported by
Bloomberg Financial Markets (or a comparable reporting service of national reputation
selected by the Company and reasonably acceptable to the Holder if Bloomberg Financial
Markets is not then reporting sales prices of such security) (collectively,
“Bloomberg”), (b) the last sales price of the Common Stock for such date (or the
nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then
listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock
are then reported in the “Pink Sheets” published by Pink OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid
price per share of the Common Stock so reported, or (d) in all other cases, the fair market
value of a share of Common Stock as determined in good faith by the Board of Directors of
the Company.

     Notwithstanding anything herein to the contrary, on the Termination Date, this
Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c)
to the extent permitted hereunder.

2

 

     d) Mechanics of Exercise.

     i. Delivery of Certificates Upon Exercise. Certificates for
shares purchased hereunder shall be transmitted by the Company’s transfer
agent to the Holder by crediting the account of the Holder’s prime broker
with The Depository Trust Company through its Deposit or Withdrawal at
Custodian system (“DWAC”) if the Company is then a participant in
such system and either (A) there is an effective registration statement
permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by Holder or (B) this Warrant is being exercised via cashless
exercise, and otherwise by physical delivery to the address specified by the
Holder in the Notice of Exercise by the date (such date, the “Warrant
Share Delivery Date”) that is three (3) Trading Days after the later of
(A) the delivery to the Company of the Notice of Exercise and (B) payment of
the aggregate Exercise Price as set forth above (including by cashless
exercise, if permitted) (such later date, the “Effective Exercise
Date”). The Warrant Shares shall be deemed to have been issued, and
Holder or any other person designated in the Notice of Exercise to become
the record holder of the Warrant Shares shall be deemed to have become a
holder of record of such shares for all purposes as of the Effective
Exercise Date, provided that all taxes required to be paid by the Holder, if
any, pursuant to Section 2(d)(iv) prior to the issuance of such shares, have
then been paid. If the Company fails for any reason to deliver to the
Holder certificates evidencing the Warrant Shares subject to a Notice of
Exercise by the Warrant Share Delivery Date, the Company shall pay to the
Holder, in cash, as liquidated damages and not as a penalty, for each $1,000
of Warrant Shares subject to such exercise (based on the Fair Market Value
of the Common Stock on the date of the applicable Effective Exercise Date),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day
after such Warrant Share Delivery Date until such certificates are
delivered.

     ii. Delivery of New Warrants Upon Exercise. If this Warrant
shall have been exercised in part, the Company shall, within ten Trading
Days after surrender of this Warrant certificate, deliver to the Holder a
new Warrant evidencing the rights of the Holder to purchase the unpurchased
Warrant Shares called for by this Warrant, which new Warrant shall in all
other respects be identical with this Warrant.

     iii. No Fractional Shares or Scrip. No fractional shares or
scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would
otherwise be entitled to purchase upon such exercise, the Company shall, at
its election, either pay a cash adjustment in respect of such final fraction
in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.

     iv. Charges, Taxes and Expenses. Issuance of certificates for
Warrant Shares shall be made without charge to the Holder for any issue or
transfer tax or other incidental expense in respect of the issuance of such
certificate, all of which taxes and expenses shall be paid by the Company,
and such certificates shall be issued in the name of the Holder or in such
name or names as may be directed by the Holder; provided,
however, that in the event certificates for Warrant Shares

3

 

are to be issued in a name other than the name of the Holder pursuant
to instructions given in the Notice of Exercise, the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any
transfer tax incidental thereto.

     v. Closing of Books. The Company will not close its
stockholder books or records in any manner which prevents the timely
exercise of this Warrant, pursuant to the terms hereof.

     vi. Compensation for Buy-In on Failure to Timely Deliver
Certificates Upon Exercise. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit
to the Holder a certificate or the certificates representing the Warrant
Shares pursuant to an exercise on or before the Warrant Share Delivery Date,
and if after such date the Holder, or any third party on behalf of the
Holder or for the Holder’s account, purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by
the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a “Buy-In”), then the Company shall (A) pay in cash
to the Holder the amount, if any, by which (x) the Holder’s total purchase
price (including brokerage commissions, if any) for the shares of Common
Stock so purchased exceeds (y) the amount obtained by multiplying (1) the
number of Warrant Shares that the Company was required to deliver to the
Holder in connection with the exercise at issue times (2) the price at which
the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and
equivalent number of Warrant Shares for which such exercise was not honored
(in which case such exercise shall be deemed rescinded) or deliver to the
Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations
hereunder. For example, if the Holder purchases Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise
to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000.
The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a
Holder’s right to pursue any equitable remedies available to it hereunder,
including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company’s failure to timely deliver
certificates representing shares of Common Stock upon exercise of the
Warrant as required pursuant to the terms hereof.

     e) [Holder’s Exercise Limitations. The Company shall not effect any exercise
of this Warrant, and a Holder shall not have the right to exercise any portion of this
Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder
(together with the Holder’s Affiliates, as defined below), and any other Persons, as defined
below. acting as a group together with the Holder or any of the Holder’s Affiliates), would
beneficially own in excess of the Beneficial Ownership Limitation (as defined below).
“Person” means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or

4

 

other entity of any kind. “Affiliate” of a Person means any other Person that,
directly or indirectly through one or more intermediaries, controls or is controlled by or
is under common control with such Person as such terms are used in and construed under Rule
405 under the Securities Act of 1933, as amended. For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates
shall include the number of shares of Common Stock issuable upon exercise of this Warrant
with respect to which such determination is being made, but shall exclude the number of
shares of Common Stock which would be issuable upon (i) exercise of the remaining,
nonexercised portion of this Warrant beneficially owned by the Holder or any of its
Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any
other securities of the Company (including, without limitation, any securities of the
Company or its which would entitle the holder thereof to acquire at any time Common Stock,
including, without limitation, any debt, preferred stock, right, option, warrant or other
instrument that is at any time convertible into or exercisable or exchangeable for, or
otherwise entitles the holder thereof to receive, Common Stock) subject to a limitation on
conversion or exercise analogous to the limitation contained herein beneficially owned by
the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for
purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it
being acknowledged by the Holder that the Company is not representing to the Holder that
such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of
whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates) and of which portion of this Warrant is exercisable shall be
in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be
deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates) and of which portion
of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such
determination. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder. For purposes of this Section 2(e), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual
report filed with the Commission, as the case may be, (B) a more recent public announcement
by the Company or (C) a more recent written notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding. Upon the written or oral
request of a Holder, the Company shall within two Trading Days confirm orally and in writing
to the Holder the number of shares of Common Stock then outstanding. In any case, the
number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder
or its Affiliates since the date as of which such number of outstanding shares of Common
Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the
issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon
not less than 61 days’ prior notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to
apply. Any such increase or decrease will not be effective until the 61st day
after such notice is delivered to the Company. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than

5

 

in strict conformity with the terms of this Section 2(e) to correct this paragraph (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation herein contained or to make changes or supplements necessary or
desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of this Warrant.]1

     Section 3. Certain Adjustments.

     a) Stock Dividends and Splits. If the Company, at any time while this Warrant
is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions
on shares of its Common Stock or any other equity or equity equivalent securities payable in
            shares of Common Stock (which, for avoidance of doubt, shall not include any shares of
Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of
            shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a
fraction of which the numerator shall be the number of shares of Common Stock (excluding
treasury shares, if any) outstanding immediately before such event and of which the
denominator shall be the number of shares of Common Stock outstanding immediately after such
event, and the number of shares issuable upon exercise of this Warrant shall be
proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain
unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective
immediately after the record date for the determination of stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.

     b) [RESERVED]

     c) Pro Rata Distributions. If the Company, at any time while this Warrant is
outstanding, shall distribute to all holders of Common Stock (and not to the Holder)
evidences of its indebtedness or assets (including cash and cash dividends) or rights or
warrants to subscribe for or purchase any security, then in each such case upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each
Warrant Share that would have been issuable upon such exercise immediately prior to the date
on which a recording taken for the distribution of such evidences of indebtedness, assets,
rights or warrants, such evidences of indebtedness, assets, rights or warrants as would have
been distributed for such Warrant Share had this Warrant been exercised for such Warrant
Share immediately prior to such record date.

     d) Fundamental Transaction. If, at any time while this Warrant is outstanding,
(i) the Company, directly or indirectly, in one or more related transactions effects any
merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related
transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or
property and has been accepted by the holders of 50% or more of the outstanding Common
Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock is

 

			
	1	 	Section 2(e) to be excluded if Investor has
elected no blocker on its signature page.

6

 

     effectively converted into or exchanged for other securities, cash or property, (v) the
Company, directly or indirectly, in one or more related transactions consummates a stock or
share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or
group of Persons whereby such other Person or group acquires more than 50% of the
outstanding shares of Common Stock (not including any shares of Common Stock held by the
other Person or other Persons making or party to, or associated or affiliated with the other
Persons making or party to, such stock or share purchase agreement or other business
combination) (each a “Fundamental Transaction”), then upon any subsequent exercise
of this Warrant, the Holder shall have the right to receive, for each Warrant Share that
would have been issuable upon such exercise immediately prior to the occurrence of such
Fundamental Transaction, such shares of stock, securities or assets as would have been
issuable or payable with respect to or in exchange for such Warrant Share had this Warrant
been exercised for such Warrant Share immediately prior to the consummation of such
Fundamental Transaction (the “Alternate Consideration”). If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in
which the Company is not the survivor (the “Successor Entity”) to assume in writing
all of the obligations of the Company under this Warrant in accordance with the provisions
of this Section 3(d) and upon the occurrence of any such Fundamental Transaction, the
Successor Entity shall succeed to, and be substituted for (so that from and after the date
of such Fundamental Transaction, the provisions of this Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the
Company and shall assume all of the obligations of the Company under this Warrant with the
same effect as if such Successor Entity had been named as the Company herein.

e) Calculations. All calculations under this Section 3 shall be made to the
nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this
Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a
given date shall be the sum of the number of shares of Common Stock (excluding treasury
            shares, if any) issued and outstanding.

f) Notice to Holder.

Whenever any adjustment is made pursuant to any provision of this Section 3,
the Company shall promptly mail to the Holder a notice setting forth such
adjustment and a brief statement of the facts requiring such adjustment.

Section 4. Transfer of Warrant.

a) Transferability. This Warrant and all rights hereunder are transferable, in
whole or in part, upon surrender of this Warrant at the principal office of the Company or
its designated agent, together with a written assignment of this Warrant in the form
attached hereto duly executed by the Holder or its agent or attorney, and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or
denominations specified in such instrument of assignment, and shall issue to the assignor a
new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall
promptly be cancelled. The Warrant, if properly

7

 

assigned in accordance herewith, may be exercised by a new holder for the purchase of
Warrant Shares prior to the issuance of a new Warrant.

b) New Warrants. This Warrant may be divided or combined with other Warrants
upon presentation hereof at the aforesaid office of the Company, together with a written
notice specifying the names and denominations in which new Warrants are to be issued, signed
by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any
transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges
shall be dated the initial issuance date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c) Warrant Register. The Company shall register this Warrant, upon records to
be maintained by the Company for that purpose (the “Warrant Register”), in the name
of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any
exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.

     Section 5. Miscellaneous.

     a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the
Holder to any voting rights, dividends or other rights as a stockholder of the Company prior
to the exercise hereof as set forth in Section 2(d)(i).

     b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants
that upon receipt by the Company of evidence reasonably satisfactory to it of the loss,
theft, destruction or mutilation of this Warrant or any stock certificate relating to the
Warrant Shares, and in case of loss, theft or destruction, of indemnity or security
reasonably satisfactory to it (which, in the case of the Warrant, shall not include the
posting of any bond), and upon surrender and cancellation of such Warrant or stock
certificate, if mutilated, the Company will make and deliver a new Warrant or stock
certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or
stock certificate.

     c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein shall not be
a Business Day (as defined below), then, such action may be taken or such right may be
exercised on the next succeeding Business Day. “Business Day” means any day except
any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by
law or other governmental action to close.

     d) Authorized Shares.

The Company covenants that, during the period the Warrant is outstanding, it will
reserve from its authorized and unissued Common Stock a sufficient number of shares
to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the
duty of executing stock certificates to execute and issue the necessary certificates
for the Warrant Shares upon the exercise of the purchase rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that
such Warrant Shares may be issued

8

 

as provided herein without violation of any applicable law or regulation, or of any
requirements of the Trading Market upon which the Common Stock may be listed. The
Company covenants that all Warrant Shares which may be issued upon the exercise of
the purchase rights represented by this Warrant will, upon exercise of the purchase
rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free
from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).

     Except and to the extent as waived or consented to by the Holder, the Company
shall not by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such
terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase
the par value of any Warrant Shares above the amount payable therefor upon such
exercise immediately prior to such increase in par value, (ii) take all such action
as may be necessary or appropriate in order that the Company may validly and legally
issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations,
exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this
Warrant.

     Before taking any action which would result in an adjustment in the number of
Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.

     e) Jurisdiction. All questions concerning the construction, validity,
enforcement and interpretation of this Warrant shall be determined in accordance with the
provisions of the Purchase Agreement.

     f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon
the exercise of this Warrant, if not registered, and if the Holder does not utilize cashless
exercise, will have restrictions upon resale imposed by state and federal securities laws.

     g) Nonwaiver and Expenses. No course of dealing or any delay or failure to
exercise any right hereunder on the part of Holder shall operate as a waiver of such right
or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other
provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly
fails to comply with any provision of this Warrant, which results in any material damages to
the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys’ fees, including
those of appellate proceedings, incurred by the Holder in collecting any amounts due
pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

9

 

     h) Notices. Any notice, request or other document required or permitted to be
given or delivered to the Holder by the Company shall be delivered in accordance with the
notice provisions of the Purchase Agreement.

     i) Limitation of Liability. No provision hereof, in the absence of any
affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no
enumeration herein of the rights or privileges of the Holder, shall give rise to any
liability of the Holder for the purchase price of any Common Stock or as a stockholder of
the Company, whether such liability is asserted by the Company or by creditors of the
Company.

     j) Remedies. The Holder, in addition to being entitled to exercise all rights
granted by law, including recovery of damages, will be entitled to specific performance of
its rights under this Warrant. The Company agrees that monetary damages would not be
adequate compensation for any loss incurred by reason of a breach by it of the provisions of
this Warrant and hereby agrees to waive and not to assert the defense in any action for
specific performance that a remedy at law would be adequate.

     k) Successors and Assigns. Subject to applicable securities laws, this Warrant
and the rights and obligations evidenced hereby shall inure to the benefit of and be binding
upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any
Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of
Warrant Shares.

     l) Amendment. This Warrant may be modified or amended or the provisions hereof
waived with the written consent of the Company and the Holder.

     m) Severability. Wherever possible, each provision of this Warrant shall be
interpreted in such manner as to be effective and valid under applicable law, but if any
provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of this Warrant.

     n) Headings. The headings used in this Warrant are for the convenience of
reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Page Follows)

10

 

     IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer
thereunto duly authorized as of the date first above indicated.

	 	 	 	 	 
	 	IDERA PHARMACEUTICALS, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

11

 

NOTICE OF EXERCISE

			
	TO:	 	IDERA PHARMACEUTICALS, INC.

     (1) The undersigned hereby elects to purchase                      Warrant Shares of the Company
pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith (or
within three Trading Days will tender) payment of the exercise price in full, together with all
applicable transfer taxes, if any.

     (2) Payment shall take the form of (check applicable box):

	 	o 	 	 in lawful money of the United States; or
	 
	 	o 	 	[if permitted] the cancellation of such number of Warrant Shares as is
necessary, in accordance with the formula set forth in subsection 2(c), to
exercise this Warrant with respect to the maximum number of Warrant Shares
purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).

     (3) Please issue a certificate or certificates representing said Warrant Shares in
the name of the undersigned or in such other name as is specified below:

	 	 	 	                                                            

The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery
of a certificate to:

	 	 	 

	 

	 	DTC #:
 

	 
	 	 
	 

	 	FBO:
 

	 
	 	 
	 

	 	Beneficiary Account #:
 

[SIGNATURE OF HOLDER]

	 	 	 

	Name of Investing Entity:

	 	 

	 	 	 

	Signature of Authorized Signatory of Investing Entity:

	 	 

	 	 	 

	Name of Authorized Signatory:

	 	 

	 	 	 

	Title of Authorized Signatory:

	 	 

	 	 	 

	Date:

	 	 

Signature Guaranteed:                                                             

NOTE: The signature to this Notice of Exercise must correspond with the name as it appears on the
face of the Warrant, without alteration or enlargement or any change whatsoever, and must be
guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to exercise the foregoing
Warrant.

 

ASSIGNMENT FORM

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

     FOR VALUE RECEIVED,                      shares of the foregoing Warrant and all rights evidenced
thereby are hereby assigned to

	 	 	 

	 

	 	whose address is

	 	 	 	 	 

	 

	. 	 		 
	 
	 	 	 	 
	 

	 	 	 	 

Date:                     ,                     

	 	 	 

	Holder’s Signature:

	 	 

	 
	 	 
	Holder’s Address:

	 	 

	 
	 	 
	 

	 	 

Signature Guaranteed:                                                             

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the
face of the Warrant, without alteration or enlargement or any change whatsoever, and must be
guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign the foregoing
Warrant.

 

Exhibit B

IDERA PHARMACEUTICALS, INC. INVESTOR QUESTIONNAIRE

AND DWAC SETTLEMENT

     Unless delivery of the Shares will be made pursuant to the delivery versus payment (“DVP”)
instructions previously provided to the Investor by the Company, in connection with the delivery of
Shares by electronic book-entry at The Depository Trust Company (“DTC”), registered in the
Investor’s name and address as set forth on the signature page of the Agreement to which this
Exhibit B is attached, and released by the Company’s transfer agent (the “Transfer Agent”), to the
Investor at the Closing, and pursuant to Section 3 of Annex I to the Agreement,
please provide us with the following information:

	 	 	 	 	 

	1.

	 	The exact name that your Shares and Warrants are to be registered in.
You may use a nominee name if appropriate:
	 	 

	 
	 	 	 	 
	2.

	 	The relationship between the Investor and the registered holder listed
in response to item 1 above:
	 	 

	 
	 	 	 	 
	3.

	 	The mailing address of the registered holder listed in response to
item 1 above:
	 	 

	 
	 	 	 	 
	4.

	 	The email address of the registered holder listed in response to item
1 above:
	 	 

	 
	 	 	 	 
	5.

	 	The Social Security Number or Tax Identification Number of the
registered holder listed in the response to item 1 above:
	 	 

	 
	 	 	 	 
	6.

	 	Name of DTC Participant (broker-dealer at which the account or
accounts to be credited with the Shares are maintained):
	 	 

	 
	 	 	 	 
	7.

	 	DTC Participant Number:
	 	 

	 
	 	 	 	 
	8.

	 	Name of Account at DTC Participant being credited with the Shares:
	 	 

	 
	 	 	 	 
	9.

	 	Account Number at DTC Participant being credited with the Shares:
	 	 

NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THE AGREEMENT TO WHICH THIS
EXHIBIT B IS ATTACHED BY THE INVESTOR AND THE COMPANY, THE INVESTOR SHALL:

	 	(I)	 	DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE
CREDITED WITH THE SHARES ARE MAINTAINED TO SET UP A DEPOSIT/WITHDRAWAL AT CUSTODIAN
(“DWAC”) ON THE CLOSING DATE INSTRUCTING THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT
OR ACCOUNTS WITH THE SHARES, AND
	 
	 	(II)	 	REMIT BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL TO THE AGGREGATE
PURCHASE PRICE FOR THE SECURITIES BEING PURCHASED BY THE INVESTOR TO THE ESCROW
ACCOUNT DESIGNATED BY THE COMPANY.exv10w1

Exhibit 10.1

EXECUTION COPY

AMENDMENT NO. 3

          AMENDMENT NO. 3 (this “Amendment”) dated as of August 2, 2010 to the Credit Agreement
referred to below, between Teleflex Incorporated (the “Borrower”), each of the Guarantors
identified under the caption “GUARANTORS” on the signature pages hereto, each of the Lenders
identified under the caption “LENDER” on the Amendment No. 3 Lender Addendum and JPMorgan Chase
Bank, N.A. (“JPMCB”), as administrative agent for the Lenders (in such capacity, the
“Administrative Agent”).

          WHEREAS, the Borrower, the Lenders party thereto (individually, a “Lender” and,
collectively, the “Lenders”), the Guarantors party thereto, JPMCB, as collateral agent for
the Lenders (in such capacity, the “Collateral Agent”), the Administrative Agent and Bank
of America, N.A., as syndication agent, are parties to a Credit Agreement dated as of October 1,
2007 (as amended and in effect immediately prior to giving effect to this Amendment, the
“Credit Agreement”); and

          WHEREAS, the Borrower, the Guarantors and the Lenders wish to amend the Credit Agreement in
certain respects;

          NOW, THEREFORE, the parties hereto hereby agree as follows:

          Section 1. Definitions. Capitalized terms used in this Amendment and not otherwise
defined are used herein as defined in the Credit Agreement.

          Section 2. Amendments. Subject to the satisfaction of the conditions precedent in,
and effective as provided in, Section 4 hereof, the Credit Agreement shall be amended as follows:

          2.01. General References. References in the Credit Agreement (including references
to the Credit Agreement as amended hereby) to “this Agreement” (and indirect references such as
“hereunder”, “hereby”, “herein” and “hereof”) shall be deemed to be references to the Credit
Agreement as amended hereby.

          2.02. Defined Terms.

          A. Section 1.01 of the Credit Agreement shall be amended by amending the following
definitions (to the extent already included in said Section 1.01) and inserting the following
definitions in the appropriate alphabetical location (to the extent not already included in said
Section 1.01):

     “Alternate Base Rate” means, for any day, a rate per annum equal to the
greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate
for such day plus 0.50% and (c) the LIBO Rate for the offering of Dollar deposits
for a one month Interest Period commencing on such day plus 1.00%. For purposes of
clause (c) of the immediately preceding sentence, such LIBO Rate shall be determined by the
Administrative Agent based upon rates appearing on Reuters Screen LIBOR01 Page and otherwise
in accordance with the definition of “LIBO Rate”, except that (i) if a given day is a
Business Day, such determination shall be made on such day (rather than two Business Days
prior to the commencement of an Interest Period) or (ii) if a given day is not a Business
Day, such LIBO Rate for such day shall be the rate determined by the Administrative Agent
pursuant to the preceding clause (i) for the most recent Business Day preceding such day.
Any change in the Alternate Base Rate due to a change in the Prime Rate, the Federal Funds
Effective Rate or such LIBO Rate shall be effective from and

 

 

- 2 -

including the effective date of such change in the Prime Rate, the Federal Funds
Effective Rate, the Prime Rate or such LIBO Rate, as the case may be.

     “Amendment No. 3” means that certain Amendment No. 3 dated as of August 2, 2010
to this Agreement, between the Borrower, the Guarantors party thereto, the Lenders party
thereto and the Administrative Agent.

     “Amendment No. 3 Effective Date” means the date on which the conditions
specified in Section 4.02 of Amendment No. 3 are satisfied (or waived by the Required
Lenders).

     “Amendment No. 3 Lender Addendum” means, with respect to any Lender, the
Amendment No. 3 Lender Addendum substantially in the form of Exhibit A to Amendment No. 3
(with such changes thereto, or in such other form, as shall be satisfactory to the
Administrative Agent).

     “Applicable Rate” means, for each day:

     (a) with respect to the Tranche 1 Revolving Credit Loans or the Tranche 1 Revolving
Credit Commitments, the applicable rate per annum set forth under the heading “ABR Spread”,
“Eurocurrency Spread” or “Commitment Fee Rate”, respectively, in the Tranche 1 Pricing Grid
based upon the Leverage Ratio as of the most recent determination date (or otherwise
determined in accordance with this definition);

     (b) with respect to the Tranche 2 Revolving Credit Loans or the Tranche 2 Revolving
Credit Commitments, the applicable rate per annum set forth under the heading “ABR Spread”,
“Eurocurrency Spread” or “Commitment Fee Rate”, respectively, in the Tranche 2 Pricing Grid
based upon the Leverage Ratio as of the most recent determination date (or otherwise
determined in accordance with this definition);

     (c) with respect to the Tranche 1 Term Loans, the applicable rate per annum set forth
under the heading “ABR Spread” or “Eurocurrency Spread” in the Tranche 1 Pricing Grid based
upon the Leverage Ratio as of the most recent determination date (or otherwise determined in
accordance with this definition); and

     (d) with respect to the Tranche 2 Term Loans, the applicable rate per annum set forth
under the heading “ABR Spread” or “Eurocurrency Spread” in the Tranche 2 Pricing Grid based
upon the Leverage Ratio as of the most recent determination date (or otherwise determined in
accordance with this definition);

provided that, for purposes of clauses (b) and (d) above only, for the period from
and including the Amendment No. 3 Effective Date to but excluding the effective date of the
next change in the Leverage Ratio pursuant to the immediately succeeding sentence, the
Applicable Rate shall be deemed to fall within Category 3 of the Tranche 2 Pricing Grid.
For purposes of the Tranche 1 Pricing Grid or the Tranche 2 Pricing Grid, as applicable
(each a “Pricing Grid”), (i) the Leverage Ratio shall be determined as of the end of
each fiscal quarter of the Borrower based upon the Borrower’s consolidated financial
statements delivered pursuant to Section 5.01(a) or (b) and (ii) each change in the
Applicable Rate resulting from a change in the Leverage Ratio shall be effective during the
period commencing on and including the date three Business Days after delivery to the
Administrative Agent of such consolidated financial statements indicating such change and
ending on the date immediately preceding the effective date of the next such change;
provided, further, that the Leverage Ratio shall be deemed to be in Category
1 of the applicable

 

- 3 -

Pricing Grid (A) at any time that an Event of Default has occurred and is continuing or (B)
if the Borrower fails to deliver the consolidated financial statements required to be
delivered by it pursuant to Section 5.01(a) or (b) during the period from the expiration of
the time for delivery thereof until such consolidated financial statements are delivered.

     “Class”, when used in reference to any Loan or Borrowing, refers to whether
such Loan, or the Loans constituting such Borrowing, are Syndicated Revolving Credit Loans,
Syndicated Term Loans, Competitive Loans or Swingline Loans. For the avoidance of doubt,
except as otherwise expressly provided herein, (a) the Tranche 1 Revolving Credit
Commitments and the Tranche 2 Revolving Credit Commitments (and the Revolving Credit Loans
made thereunder) shall be considered to be the same Class and (b) the Tranche 1 Term Loans
and the Tranche 2 Term Loans shall be considered to be the same Class.

     “Commitment” means a Revolving Credit Commitment, a New Tranche 2 Revolving
Credit Commitment, a Term Loan Commitment, a New Tranche 2 Term Loan Commitment, an
Incremental Revolving Credit Commitment or an Incremental Term Loan Commitment, or any
combination thereof (as the context requires) and without duplication.

     “Consolidated EBITDA” means, for any period, the sum, for the Borrower and its
Subsidiaries (determined on a consolidated basis without duplication in accordance with
GAAP), of the following:

     (a) Consolidated Net Income for such period;

     plus (b) without duplication and to the extent reflected as a charge in the
income statement for such period, the sum of:

     (i) income tax expense;

     (ii) Consolidated Interest Expense, amortization or writeoff of debt discount
and debt issuance costs and commissions, discounts and other fees and charges
associated with Indebtedness (including the Loans);

     (iii) depreciation and amortization expense, including amortization of
intangibles (including, but not limited to, goodwill);

     (iv) transaction costs, fees and expenses related to the Arrow Acquisition, the
Transactions and the Senior Notes Transactions in an aggregate amount not exceeding
$30,000,000;

     (v) non-recurring charges and expenses related to the closing of certain of the
Borrower’s facilities in an aggregate amount not exceeding $15,000,000 through
September 30, 2008;

     (vi) non-recurring integration costs and expenses related to the Arrow
Acquisition in an aggregate amount not exceeding $45,000,000 for the period from the
Effective Date through December 31, 2009;

     (vii) non-cash costs associated with inventory purchase price adjustments and
in-process research and development for the period from the Effective Date through
December 31, 2008;

 

- 4 -

     (viii) non-cash stock-based compensation expense relating to stock options and
restricted stock granted to employees and directors, and cash-based option expenses
and change of control payments related to the Arrow Acquisition in an aggregate
amount not exceeding $45,000,000 through September 30, 2008;

     (ix) other extraordinary, unusual or non-recurring non-cash charges;

     (x) net cost savings and other acquisition synergies directly attributable to
the Arrow Acquisition within one year of the date hereof that are projected by the
Borrower in good faith to result therefrom and supportable or quantifiable by
appropriate records in an aggregate amount not exceeding (A) $34,400,000 for the
period of four consecutive fiscal quarters ended September 30, 2007, (B) $33,000,000
for the period of four consecutive fiscal quarters ended December 31, 2007, (C)
$29,000,000 for the period of four consecutive fiscal quarters ended March 31, 2008,
(D) $24,000,000 for the period of four consecutive fiscal quarters ended June 30,
2008 and (E) $17,000,000 for the period of four consecutive fiscal quarters ended
September 30, 2008 (it being understood that any amounts to be added to Consolidated
Net Income for any such period pursuant to this clause (x) shall not include any
amounts that have been taken into account in the determination of the Consolidated
Net Income for such period); and

     (xi) if at any time on or after the Amendment No. 3 Effective Date either (A)
all of the outstanding Senior Notes have been paid or prepaid in full or (B) all of
the outstanding Senior Notes (and the related Senior Note Purchase Agreements) shall
have been amended to provide for an add-back for purposes of the definition
contained therein corresponding to this definition for (I) transaction costs, fees
and expenses related to the prepayment of Term Loans contemplated by Section 4.02(c)
of Amendment No. 3 and/or (II) make-whole amounts and/or prepayment penalties or
premiums paid by the Borrower on or after the Amendment No. 3 Effective Date in
respect of the prepayment of any Senior Notes, then, effective upon written notice
by the Borrower to the Administrative Agent of such payment or prepayment or upon
receipt by the Administrative Agent of a signed copy of such amendment(s) reasonably
acceptable to the Administrative Agent, as applicable, this definition shall
automatically be deemed amended to include (x) in the case of (A) above, both such
add-backs referred to in (I) and (II) above and (y) in the case of (B) above, either
or both of such add-backs to the extent permitted under the Senior Notes as so
amended;

     minus (c) to the extent included in the statement of such Consolidated Net
Income for such period, extraordinary, unusual or non-recurring income or gains;

provided that with respect to any such period in which (x) the Arrow Acquisition
shall have been consummated, (y) any Person consolidates with or merges with the Borrower or
any Subsidiary, or conveys, transfers or leases all or substantially all of its assets in a
single transaction or series of transactions to the Borrower or any Subsidiary, and
concurrently therewith becomes a Subsidiary, in a transaction constituting a Material
Acquisition or (z) any Person ceases to be a Subsidiary during such period, or the Borrower
or any Subsidiary shall have made a Material Disposition, EBITDA for such period shall be
calculated on a pro forma basis so as to give effect to such event as of the first day of
such period; provided, further, that any operations classified as
“discontinued operations” shall be included in the calculation of Consolidated EBITDA. As
used in this definition, “Material Acquisition” means any Acquisition of property or
series of related Acquisitions that involves the payment of consideration by the Borrower
and its Subsidiaries in

 

- 5 -

excess of $10,000,000; and “Material Disposition” means any Disposition of property
or series of related Dispositions of property that yields gross proceeds to the Borrower and
its Subsidiaries in excess of $10,000,000.

     “Convertible Notes” means the convertible notes of the Borrower issued pursuant
to Section 6.01(i).

     “Credit Party” means the Administrative Agent, any Issuing Lender, the
Swingline Lender and any other Revolving Credit Lender.

     “Dollar Revolving Credit Sub-Commitment” means, with respect to each Dollar
Revolving Credit Lender, the commitment, if any, of such Dollar Revolving Credit Lender to
make Syndicated Revolving Credit Loans in Dollars and to acquire participations in Letters
of Credit denominated in Dollars and Swingline Loans hereunder, expressed as an amount
representing the maximum aggregate amount of such Lender’s Dollar Revolving Credit Exposure
hereunder, as such commitment may be (a) reduced pursuant to Section 2.09 or increased
pursuant to Section 2.20 from time to time and (b) reduced or increased from time to time
pursuant to assignments by or to such Lender pursuant to Section 9.04. The amount of each
Revolving Credit Lender’s Dollar Revolving Credit Sub-Commitment under the respective
Tranches as of the Amendment No. 3 Effective Date is set forth on Schedule 2.01, or in the
Assignment and Assumption or other agreement entered into under Section 2.20 pursuant to
which such Lender shall have assumed its Dollar Revolving Credit Commitment, as applicable.

     “Guarantors” means (a) each Domestic Subsidiary of the Borrower as of the
Effective Date (after giving effect to the Arrow Acquisition, but excluding any Excluded
Subsidiary and any Released Subsidiary) and (b) each other Subsidiary of the Borrower that
shall become a Guarantor pursuant to Section 5.09, in each case so long as such Subsidiary
shall remain a Guarantor party hereto.

     “Incremental Lender” has the meaning assigned to such term in Section 2.20.

     “Incremental Loan Effective Date” has the meaning assigned to such term in
Section 2.20.

     “Incremental Revolving Credit Commitment” has the meaning assigned to such term
in Section 2.20.

     “Incremental Revolving Credit Lender” has the meaning assigned to such term in
Section 2.20.

     “Incremental Term Lender” has the meaning assigned to such term in Section
2.20.

     “Incremental Term Loan” has the meaning assigned to such term in Section 2.20.

     “Incremental Term Loan Commitment” has the meaning assigned to such term in
Section 2.20.

     “Lenders” means the Persons listed on Schedule 2.01 and any other Person that
shall have become a party hereto pursuant to an Assignment and Assumption or other agreement
entered into pursuant to Section 2.20, other than any such Person that ceases to be a party
hereto

 

- 6 -

pursuant to an Assignment and Assumption. Unless the context otherwise requires, the term
“Lenders” includes the Swingline Lender.

     “Multicurrency Revolving Credit Sub-Commitment” means, with respect to each
Multicurrency Revolving Credit Lender, the commitment, if any, of such Multicurrency
Revolving Credit Lender to make Syndicated Revolving Credit Loans and to acquire
participations in Letters of Credit hereunder, in each case in Dollars or an Agreed Foreign
Currency, expressed as a Dollar amount representing the Dollar Equivalent of the maximum
aggregate amount of such Lender’s Multicurrency Revolving Credit Exposure hereunder, as such
commitment may be (a) reduced pursuant to Section 2.09 or increased pursuant to Section 2.20
from time to time and (b) reduced or increased from time to time pursuant to assignments by
or to such Lender pursuant to Section 9.04. The amount of each Revolving Credit Lender’s
Multicurrency Revolving Credit Sub-Commitment under the respective Tranches as of the
Amendment No. 3 Effective Date is set forth on Schedule 2.01, or in the Assignment and
Assumption or other agreement entered into under Section 2.20 pursuant to which such Lender
shall have assumed its Multicurrency Revolving Credit Commitment, as applicable.

     “New Tranche 2 Revolving Credit Lender” means a Person (including a Revolving
Credit Lender immediately prior to the Amendment No. 3 Effective Date) which has agreed
pursuant to an Amendment No. 3 Lender Addendum to be a Tranche 2 Revolving Credit Lender and
provide a New Tranche 2 Revolving Credit Commitment as of the Amendment No. 3 Effective Date
(which may be effected by assignment of all or a portion of one or more Revolving Credit
Commitments from one or more existing Revolving Credit Lenders as of the Amendment No. 3
Effective Date).

     “New Tranche 2 Revolving Credit Commitment” means, with respect to each New
Tranche 2 Revolving Credit Lender, the Tranche 2 Revolving Credit Commitment of such Lender
in the amount set forth on Schedule 2.01.

     “New Tranche 2 Term Lender” means a Person (including a Term Lender immediately
prior to the Amendment No. 3 Effective Date) which has agreed pursuant to an Amendment No. 3
Lender Addendum to be a Tranche 2 Term Lender and provide a New Tranche 2 Term Loan
Commitment as of the Amendment No. 3 Effective Date (which may be effected by assignment of
all or a portion of one or more Term Loans from one or more existing Term Lenders as of the
Amendment No. 3 Effective Date).

     “New Tranche 2 Term Loan Commitment” means, with respect to each New Tranche 2
Term Lender, the commitment of such Lender to make a Syndicated Term Loan hereunder on the
Amendment No. 3 Effective Date in the amount set forth on Schedule 2.01.

     “Prepayment Event” means (a) any Asset Sale, (b) any Prepayment Asset Sale, (c)
any Recovery Event, (d) any the issuance or incurrence of any Indebtedness or (e) any
Qualifying Convertible Notes Payment.

     “Qualifying Convertible Notes” means (a) the Convertible Notes issued as of the
Amendment No. 3 Effective Date and (b) any other “Qualifying Convertible Notes” (as such
term is defined in the Senior Note Purchase Agreements, as amended as of the Convertible
Notes Amendments Effective Date (as such term is defined in Amendment No. 3)) issued after
the Amendment No. 3 Effective Date.

 

- 7 -

     “Qualifying Convertible Notes Payment” means the sum of all payments in cash by
the Borrower in respect of Qualifying Convertible Notes to any holders thereof made or paid
in connection with the exercise by such holders of their right to require repurchase upon a
fundamental change (as defined under the indenture governing such series of Qualifying
Convertible Notes) and/or in connection with the exercise by such holders of their
conversion rights and the Borrower satisfies its conversion obligation upon such exercise in
full or in part in cash, and the aggregate amount of all such cash payments exceeds
$30,000,000 (such amount, the “Qualifying Convertible Notes Payment Amount”);
provided that, following the occurrence of the first Qualifying Convertible Notes
Payment (if any), the Qualifying Convertible Notes Payment Amount shall be reduced from
$30,000,000 to $5,000,000.

     “Qualifying Convertible Notes Payment Amount” has the meaning assigned to such
term in the definition of “Qualifying Convertible Notes Payment”.

     “Released Subsidiary” means any Subsidiary listed on Schedule 1 to Amendment
No. 3.

     “Relevant Application Date” means (a) with respect to any issuance or
incurrence of any Indebtedness, the date of such incurrence or issuance, (b) with respect to
any Recovery Event, (i) the fifth Business Day after such Recovery Event (unless, prior
thereto, a Reinvestment Notice shall have been delivered to the Administrative Agent in
respect thereof) and (ii) each Reinvestment Prepayment Date with respect thereto, (c) with
respect to any Asset Sale, the fifth Business Day after such Asset Sale, (d) with respect to
any Prepayment Asset Sale, the date on which the Term Loans are required to be prepaid
pursuant to the proviso contained in Section 6.04(f), (e) with respect to any Qualifying
Convertible Notes Payment, the date of such payment is made by the Borrower and (f) with
respect to any Prepayment Event, the Business Day immediately following the expiration of
the relevant period for acceptance of the offer to prepay the Senior Notes under the
relevant Senior Note Purchase Agreement as a result of such Prepayment Event.

     “Relevant Share” means, with respect to any Prepayment Event, (a) as of the
initial Relevant Application Date therefor, a ratio equal to (i) the aggregate outstanding
principal amount of the Term Loans on such date over (ii) the sum of the aggregate
outstanding principal amount of the Term Loans plus the aggregate outstanding
principal amount of the Senior Notes under the Senior Note Purchase Agreements that require
the Borrower to make an offer to prepay such Senior Notes as a result of such Prepayment
Event and (b) as of the relevant Business Day with respect to such Prepayment Event
determined under clause (f) of the definition of “Relevant Application Date”, the remaining
portion of such Net Cash Proceeds (if any) that the Borrower is not required to apply to the
prepayment of such Senior Notes pursuant to such Senior Note Purchase Agreements.

     “Revolving Credit Commitment” means a Tranche 1 Revolving Credit Commitment or
a Tranche 2 Revolving Credit Commitment, and shall include an Incremental Revolving Credit
Commitment.

     “Revolving Credit Commitment Termination Date” means (a) with respect to the
Tranche 1 Revolving Credit Commitments, the Tranche 1 Revolving Credit Commitment
Termination Date, and (b) with respect to the Tranche 2 Revolving Credit Commitments, the
Tranche 2 Revolving Credit Commitment Termination Date.

     “Revolving Credit Lender” means a Tranche 1 Revolving Credit Lender or a
Tranche 2 Revolving Credit Lender (including an Incremental Revolving Credit Lender).

 

- 8 -

     “Revolving Credit Loans” means the Tranche 1 Revolving Credit Loans and the
Tranche 2 Revolving Credit Loans.

     “Term Lender” means a Tranche 1 Term Lender, a Tranche 2 Term Lender or
(without duplication) an Incremental Term Lender.

     “Term Loan Maturity Date” means (a) with respect to the Tranche 1 Term Loans,
the Tranche 1 Term Loan Maturity Date, and (b) with respect to the Tranche 2 Term Loans, the
Tranche 2 Term Loan Maturity Date.

     “Term Loans” means the Tranche 1 Term Loans, the Tranche 2 Term Loans and
(without duplication) the Incremental Term Loans.

     “Tranche” means (a) when used in reference to any Revolving Credit Lender,
Revolving Credit Commitment or Revolving Credit Loan or Borrowing, refers to whether such
Lender is a Tranche 1 Revolving Credit Lender or a Tranche 2 Revolving Credit Lender, such
Revolving Credit Commitment is a Tranche 1 Revolving Credit Commitment or a Tranche 2
Revolving Credit Commitment or such Revolving Credit Loan is a Tranche 1 Revolving Credit
Loan or a Tranche 2 Revolving Credit Loan or (b) when used in reference to any Term Lender
or Term Loan or Borrowing, refers to whether such Lender is a Tranche 1 Term Lender or a
Tranche 2 Term Lender or such Term Loan is a Tranche 1 Term Loan or a Tranche 2 Term Loan.

     “Tranche 1 Pricing Grid” means the following pricing grid:

 

- 9 -

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	Commitment Fee
	 	 	 	 	 	 	 	 	 	 	 	 	Rate
	 	 	 	 	 	 	 	 	 	 	 	 	(Tranche 1
	 	 	Leverage	 	ABR	 	Eurocurrency	 	Revolving Credit
	 	 	Ratio	 	Spread	 	Spread	 	Commitments only)
	Category 1:
	 	> 3.75 to 1	 	 	0.50	%	 	 	1.50	%	 	 	0.30	%
	 
	Category 2:
	 	> 3.00 to 1 and
< 3.75 to 1	 	 	0.25	%	 	 	1.25	%	 	 	0.25	%
	 
	Category 3:
	 	> 2.25 to 1 and
< 3.00 to 1	 	 	0	%	 	 	1.00	%	 	 	0.225	%
	 
	Category 4:
	 	> 1.50 to 1 and
< 2.25 to 1	 	 	0	%	 	 	0.875	%	 	 	0.20	%
	 
	Category 5:
	 	> 0.75 to 1 and
< 1.50 to 1	 	 	0	%	 	 	0.75	%	 	 	0.175	%
	 
	Category 6:
	 	< 0.75 to 1	 	 	0	% 	 	 	0.625	%	 	 	 0.15	%

     “Tranche 1 Revolving Credit Availability Period” means the period from and
including the Effective Date to but excluding the earlier of the Tranche 1 Revolving Credit
Commitment Termination Date and the date of termination of the Tranche 1 Revolving Credit
Commitments.

     “Tranche 1 Revolving Credit Commitment” means, with respect to each Tranche 1
Revolving Credit Lender, its Dollar Revolving Credit Sub-Commitment and/or its Multicurrency
Revolving Credit Sub-Commitment, if any.

     “Tranche 1 Revolving Credit Commitment Termination Date” means October 1, 2012
(or if such day is not a Business Day, the immediately preceding Business Day).

     “Tranche 1 Revolving Credit Lenders” means the Revolving Credit Lenders that
are not Tranche 2 Revolving Credit Lenders.

     “Tranche 1 Revolving Credit Loans” means the loans made by the Tranche 1
Revolving Credit Lenders pursuant to Section 2.01(a)(i).

     “Tranche 1 Term Lenders” means the Term Lenders that are not Tranche 2 Term
Lenders or Incremental Term Lenders.

     “Tranche 1 Term Loan Maturity Date” means October 1, 2012 (or if such day is
not a Business Day, the immediately preceding Business Day).

     “Tranche 1 Term Loans” means the term loans held by the Tranche 1 Term Lenders.

 

- 10 -

     “Tranche 1 Termination Date” means the date on which each of the following
shall have occurred: (a) the Tranche 1 Revolving Credit Commitment Termination Date, (b) no
Revolving Credit Exposure by the Tranche 1 Revolving Credit Lenders shall be outstanding and
(c) the Tranche 1 Term Loans shall be paid in full.

     “Tranche 2 Pricing Grid” means the following pricing grid:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Leverage	 	ABR	 	Eurocurrency	 	Commitment
	 	 	Ratio	 	Spread	 	Spread	 	Fee Rate
	Category 1:
	 	> 3.75 to 1	 	 	1.75	%	 	 	2.75	%	 	 	0.50	%
	 
	Category 2:
	 	> 3.00 to 1 and   < 3.75 to 1
	 	 	1.50	%	 	 	2.50	%	 	 	0.50	%
	 
	Category 3:
	 	> 2.25 to 1 and   < 3.00 to 1
	 	 	1.25	%	 	 	2.25	%	 	 	0.375	%
	 
	Category 4:
	 	> 1.50 to 1 and   < 2.25 to 1
	 	 	1.00	%	 	 	2.00	%	 	 	0.375	%
	 
	Category 5:
	 	> 0.75 to 1 and   < 1.50 to 1
	 	 	0.75	%	 	 	1.75	%	 	 	0.375	%
	 
	Category 6:
	 	< 0.75 to 1	 	 	0.50	%	 	 	1.50	%	 	 	0.375	%

     “Tranche 2 Revolving Credit Availability Period” means the period from and
including the Amendment No. 3 Effective Date to but excluding the earlier of the Tranche 2
Revolving Credit Commitment Termination Date and the date of termination of the Tranche 2
Revolving Credit Commitments.

     “Tranche 2 Revolving Credit Commitment” means, with respect to each Tranche 2
Revolving Credit Lender, its Dollar Revolving Credit Sub-Commitment and/or its Multicurrency
Revolving Credit Sub-Commitment, if any.

     “Tranche 2 Revolving Credit Commitment Termination Date” means October 1, 2014
(or if such day is not a Business Day, the immediately preceding Business Day).

     “Tranche 2 Revolving Credit Lenders” means (a) each Revolving Credit Lender
with a Revolving Credit Commitment that has agreed pursuant to an Amendment No. 3 Lender
Addendum to be a “Tranche 2 Revolving Credit Lender”, (b) each New Tranche 2 Revolving
Credit Lender and (c) each Incremental Revolving Credit Lender.

     “Tranche 2 Revolving Credit Loans” means the loans made by the Tranche 2
Revolving Credit Lenders pursuant to Section 2.01(a)(ii).

     “Tranche 2 Term Lenders” means (a) each Term Lender which holds a Term Loan
that has agreed pursuant to an Amendment No. 3 Lender Addendum to be a “Tranche 2 Term
Lender”

 

- 11 -

hereunder, (b) each New Tranche 2 Term Lender and (c) each Incremental Term Lender that
makes an Incremental Term Loan that is treated as a Tranche 2 Term Loan pursuant to Section
2.20.

     “Tranche 2 Term Loan Maturity Date” means October 1, 2014 (or if such day is
not a Business Day, the immediately preceding Business Day).

     “Tranche 2 Term Loan Principal Payment Dates” means (a) the Quarterly Dates of
each year, commencing with the Quarterly Date falling on or nearest to December 31, 2012
through the Quarterly Date falling on or nearest to June 30, 2014 and (b) the Tranche 2 Term
Loan Maturity Date.

     “Tranche 2 Term Loans” means the term loans held by the Tranche 2 Term Lenders.

          B. The following definitions in Section 1.01 of the Credit Agreement shall be deleted in
their entirety: “Assuming Revolving Credit Lender”; “Increasing Revolving Credit
Lender”; “Principal Payment Date”; “Revolving Credit Commitment Increase” and
“Revolving Credit Commitment Increase Date”.

          C. GAAP. Section 1.04 of the Credit Agreement will be amended and restated in its
entirety to read as follows:

     “SECTION 1.04. Accounting Terms; GAAP. Except as otherwise expressly provided
herein, all terms of an accounting or financial nature shall be construed in accordance with
GAAP, as in effect from time to time; provided that, if the Borrower notifies the
Administrative Agent that the Borrower requests to eliminate the effect of any change
occurring after the date hereof in GAAP or in the application thereof on the operation of
any provision hereof (or if the Administrative Agent notifies the Borrower that the Required
Lenders request such elimination of a change in GAAP), regardless of whether any such notice
is given before or after such change in GAAP or in the application thereof, then such
provision shall be interpreted on the basis of GAAP as in effect and applied immediately
before such change shall have become effective until such notice shall have been withdrawn
or such provision is amended in accordance with Section 9.02. To enable the ready and
consistent determination of compliance with the covenants set forth in Article VI, the
Borrower will not change the last day of its fiscal year and fiscal quarters in effect on
the date hereof.”

          2.03. Revolving Credit Loans. Section 2.01(a) of the Credit Agreement shall be
amended and restated in its entirety to read as follows:

     “(a) Revolving Credit Loans.

     (i) Subject to the terms and conditions set forth herein, (A) each Dollar Revolving
Credit Lender that is a Tranche 1 Revolving Credit Lender agrees to make Syndicated
Revolving Credit Loans in Dollars to the Borrower from time to time during the Tranche 1
Revolving Credit Availability Period in an aggregate principal amount that will not result
in (x) such Lender’s Dollar Revolving Credit Exposure exceeding such Lender’s Dollar
Revolving Credit Sub-Commitment, (y) the total Dollar Revolving Credit Exposures exceeding
the aggregate amount of the Dollar Revolving Credit Sub-Commitments or (z) the sum of the
total Revolving Credit Exposures plus the aggregate principal amount of outstanding
Competitive Loans exceeding the aggregate amount of the Revolving Credit Commitments and (B)
each Multicurrency Revolving Credit Lender that is a Tranche 1 Revolving Credit Lender
agrees to make Syndicated Revolving

 

- 12 -

Credit Loans in Dollars or in any Agreed Foreign Currency to the Borrower from time to
time during the Tranche 1 Revolving Credit Availability Period in an aggregate principal
amount that will not result in (x) such Lender’s Multicurrency Revolving Credit Exposure
exceeding such Lender’s Multicurrency Revolving Credit Sub-Commitment, (y) the total
Multicurrency Revolving Credit Exposures exceeding the aggregate amount of the Multicurrency
Revolving Credit Sub-Commitments or (z) the sum of the total Revolving Credit Exposures
plus the aggregate principal amount of outstanding Competitive Loans exceeding the
aggregate amount of the Revolving Credit Commitments.

     (ii) Subject to the terms and conditions set forth herein, (A) each Dollar Revolving
Credit Lender that is a Tranche 2 Revolving Credit Lender agrees to make Syndicated
Revolving Credit Loans in Dollars to the Borrower from time to time during the Tranche 2
Revolving Credit Availability Period in an aggregate principal amount that will not result
in (x) such Lender’s Dollar Revolving Credit Exposure exceeding such Lender’s Dollar
Revolving Credit Sub-Commitment, (y) the total Dollar Revolving Credit Exposures exceeding
the aggregate amount of the Dollar Revolving Credit Sub-Commitments or (z) the sum of the
total Revolving Credit Exposures plus the aggregate principal amount of outstanding
Competitive Loans exceeding the aggregate amount of the Revolving Credit Commitments and (B)
each Multicurrency Revolving Credit Lender that is a Tranche 2 Revolving Credit Lender
agrees to make Syndicated Revolving Credit Loans in Dollars or in any Agreed Foreign
Currency to the Borrower from time to time during the Tranche 2 Revolving Credit
Availability Period in an aggregate principal amount that will not result in (x) such
Lender’s Multicurrency Revolving Credit Exposure exceeding such Lender’s Multicurrency
Revolving Credit Sub-Commitment, (y) the total Multicurrency Revolving Credit Exposures
exceeding the aggregate amount of the Multicurrency Revolving Credit Sub-Commitments or (z)
the sum of the total Revolving Credit Exposures plus the aggregate principal amount
of outstanding Competitive Loans exceeding the aggregate amount of the Revolving Credit
Commitments.

     (iii) Within the foregoing limits and subject to the terms and conditions set forth
herein, the Borrower may borrow, prepay and reborrow Syndicated Revolving Credit Loans.

     (iv) Notwithstanding anything herein to the contrary, so long as any Tranche 1
Revolving Credit Commitment shall be in effect , but subject to Section 2.01(a)(v), the
Borrower will not borrow Revolving Credit Loans of any Tranche unless it shall
simultaneously borrow Revolving Credit Loans of the other Tranche(s) and, in the case of
Eurocurrency Loans, in the same Currency and with the same Interest Period, in an aggregate
amount such that the Revolving Credit Loan made by each Revolving Credit Lender on the
occasion of such borrowing shall equal its Applicable Dollar Percentage or Applicable
Multicurrency Percentage, as applicable, of the aggregate amount borrowed.

     (v) Notwithstanding any other provision of this Agreement, at any time after the
Amendment No. 3 Effective Date any Tranche 1 Revolving Credit Lender may, with the agreement
of the Borrower and the consent of the Administrative Agent (such consent not to
unreasonably withheld), convert all (but not less than all) of its Tranche 1 Revolving
Credit Commitment and related Revolving Credit Exposure (including Tranche 1 Revolving
Credit Loans) to a Tranche 2 Revolving Credit Commitment and Revolving Credit Exposure of
such Tranche (including Tranche 2 Revolving Credit Loans), and as of the effective date of
such conversion such Lender’s Revolving Credit Commitment (and related Revolving Credit
Exposure) shall be deemed to be a Tranche 2 Revolving Credit Commitment (and such Revolving
Credit Exposure shall be outstanding under such Tranche).”

 

- 13 -

          2.04. Term Loans. Section 2.01(b) of the Credit Agreement shall be amended by
inserting, immediately after the first sentence thereof, the following new sentences to read as
follows:

“Subject to the terms and conditions set forth herein, each New Tranche 2 Term Lender agrees
to make a Syndicated Term Loan in Dollars to the Borrower on the Amendment No. 3 Effective
Date in a principal amount equal to its New Tranche 2 Term Loan Commitment; provided
that, notwithstanding anything herein to the contrary, such new Syndicated Term Loans shall
be proportionately in the same Types of Loans as the Term Loans outstanding as of the
Amendment No. 3 Effective Date (after giving effect to the prepayment of such Term Loans
contemplated by Section 4.02(c) of Amendment No. 3) and, in the case of Eurocurrency Loans,
having an Interest Period or Interest Periods ending on the last day(s) of the Interest
Period(s) for such outstanding Eurocurrency Term Loans. Notwithstanding any other provision
of this Agreement, at any time after the Amendment No. 3 Effective Date any Tranche 1 Term
Lender may, with the agreement of the Borrower and the consent of the Administrative Agent
(such consent not to unreasonably withheld), convert all (but not less than all) of its
Tranche 1 Term Loan to a Tranche 2 Term Loan.”

          2.05. Loans and Borrowings. Section 2.02(d) of the Credit Agreement shall be amended
and restated in its entirety to read as follows:

     “(d) Limitations on Interest Periods. Notwithstanding any other provision of
this Agreement, the Borrower shall not be entitled to request (or to elect to convert to or
continue as a Syndicated Eurocurrency Borrowing) (i) any Revolving Credit Eurodollar
Borrowing if the Interest Period requested therefor would end after (x) at any time prior to
the Tranche 1 Revolving Credit Commitment Termination Date, the Tranche 1 Revolving Credit
Commitment Termination Date or (y) thereafter, the Tranche 2 Revolving Credit Commitment
Termination Date or (ii) any Term Eurodollar Borrowing if the Interest Period requested
therefor would end after (x) at any time prior to the Tranche 1 Term Loan Maturity Date, the
Tranche 1 Term Loan Maturity Date or (y) thereafter, the Tranche 2 Term Loan Maturity Date.”

          2.06. Competitive Bid Procedure. Section 2.04(a) of the Credit Agreement shall be
amended by replacing the words “during the Revolving Credit Availability Period” with the words
“prior to the termination of the Revolving Credit Commitments”.

          2.07. Swingline Loans. Section 2.05 of the Credit Agreement shall be amended as
follows:

          A. Section 2.05(a) shall be amended by replacing the words “during the Revolving Credit
Availability Period” with the words “prior to the termination of the Revolving Credit Commitments”.

          B. Section 2.05(c) shall be amended by amended by inserting a new sentence at the end of the
second paragraph hereof to read as follows:

“For avoidance of doubt, so long as any Tranche 1 Revolving Credit Commitment shall be in
effect, the allocations contemplated by the immediately preceding sentence shall be made
ratably between the Tranche 1 Revolving Credit Commitments and the Tranche 2 Revolving
Credit Commitments, such that the Revolving Credit Lenders shall have participations in the
outstanding Swingline Loans in accordance with their respective Dollar Applicable Percentage
or Multicurrency Applicable Percentage (as applicable) thereof.

 

- 14 -

          2.08. Letters of Credit. Section 2.06 of the Credit Agreement shall be amended as
follows:

          A. Section 2.06(a) shall be amended by replacing the words “during the Revolving Credit
Availability Period” in the first sentence thereof with the words “prior to the termination of the
Revolving Credit Commitments”.

          B. Section 2.06(c) shall be amended by inserting a new sentence at the end thereof to read as
follows:

“Notwithstanding any provision in this Agreement to the contrary, at no time prior to the
Tranche 1 Revolving Credit Commitment Termination Date shall the sum of the total LC
Exposure with respect to Letters of Credit that expire after the fifth Business Day prior to
the Tranche 1 Revolving Credit Commitment Termination Date plus (without
duplication) the total Revolving Credit Exposure of the Tranche 2 Revolving Credit Lenders
plus the aggregate principal amount of outstanding Competitive Loans made by the
Tranche 2 Revolving Credit Lenders exceed the aggregate amount of the Tranche 2 Revolving
Credit Commitments.”

          C. Section 2.06(d) shall be amended and restated in its entirety to read as follows:

     “(d) Expiration Date. Each Letter of Credit shall expire at or prior to the
close of business on the earlier of (i) the date twelve months after the date of the
issuance of such Letter of Credit (or, in the case of any renewal or extension thereof,
twelve months after the then-current expiration date of such Letter of Credit, so long as
such renewal or extension occurs within three months of such then-current expiration date)
and (ii) the date that is five Business Days prior to the Tranche 1 Revolving Credit
Commitment Termination Date; provided that Letters of Credit may expire after the
date specified in clause (ii) above so long as (x) the date of issuance of such Letter of
Credit is after the Tranche 1 Revolving Credit Commitment Termination Date or (y) on the
date of such issuance, the sum of (1) the face amount of such Letter of Credit plus
(2) the aggregate undrawn amount of all other outstanding Letters of Credit with an
expiration date after the fifth Business Day prior to the Tranche 1 Revolving Credit
Commitment Termination Date plus (3) (without duplication) the sum of the total
Revolving Credit Exposure of the Tranche 2 Revolving Credit Lenders plus the
aggregate principal amount of outstanding Competitive Loans made by the Tranche 2 Revolving
Credit Lenders, shall not exceed the aggregate amount of the Tranche 2 Revolving Credit
Commitments; provided, further, that in no event shall any such Letter of
Credit expire later than five Business Days prior to the Tranche 2 Revolving Credit
Commitment Termination Date.”

          D. Section 2.06(e) shall be amended by inserting a new paragraph at the end thereof to read
as follows:

     “Notwithstanding anything contained herein or in any other Loan Document to the
contrary, unless the Revolving Credit Commitments shall theretofore have terminated pursuant
to Article VII, as of the Tranche 1 Revolving Credit Commitment Termination Date, the
interests and participations of the Tranche 1 Revolving Credit Lenders in the Letters of
Credit (if any) then outstanding shall automatically terminate, whereupon (i) the Tranche 1
Revolving Credit Lenders shall have no liability arising from, relating to or in connection
with such interests and participations or otherwise in respect of such Letters of Credit and
(ii) such interests and participations in such Letters of Credit shall automatically and
without further action be re-allocated to the extent necessary such that the interests and
participations in such Letters of Credit

 

- 15 -

hereunder shall be held by the Tranche 2 Revolving Credit Lenders ratably in proportion
to their respective Tranche 2 Revolving Credit Commitments.”

          2.09. Change of Commitments. Section 2.09 of the Credit Agreement shall be amended
as follows:

          A. Section 2.09(a) shall be amended and restated in its entirety to read as follows:

     “(a) Scheduled Termination. Unless previously terminated, (i) the New Tranche
2 Term Loan Commitments shall terminate at 5:00 p.m., New York City time, on the Amendment
No. 3 Effective Date, (ii) the Tranche 1 Revolving Credit Commitments shall terminate on the
Tranche 1 Revolving Credit Commitment Termination Date and (iii) the Tranche 2 Revolving
Credit Commitments shall terminate on the Tranche 2 Revolving Credit Commitment Termination
Date.”

          B. Section 2.09(c) shall be amended by inserting a new sentence at the end thereof to read as
follows:

“For avoidance of doubt, at any time prior to the Tranche 1 Revolving Credit Commitment
Termination Date each reduction of the Revolving Credit Commitments (and either Revolving
Credit Sub-Commitment) shall be applied ratably to the Tranche 1 Revolving Credit
Commitments and the Tranche 2 Revolving Credit Commitments.”

          C. Section 2.09(d) shall be deleted in its entirety, and each reference in the Credit
Agreement to “Section 2.09(d)” shall be deemed to refer to “Section 2.20” of the Credit Agreement.

          2.10. Repayment of Loans. Section 2.10 of the Credit Agreement shall be amended as
follows:

          A. Section 2.10(a)(i) shall be amended and restated in its entirety to read as follows:

     “(i) The Borrower hereby unconditionally promises to pay to the Administrative Agent
(A) for the account of each Tranche 1 Revolving Credit Lender the outstanding principal
amount of the Syndicated Tranche 1 Revolving Credit Loans of such Lender on the Tranche 1
Revolving Credit Commitment Termination Date and (B) for the account of each Tranche 2
Revolving Credit Lender the outstanding principal amount of the Syndicated Tranche 2
Revolving Credit Loans of such Lender on the Tranche 2 Revolving Credit Commitment
Termination Date.”

          B. Section 2.10(a)(iii) shall be amended and restated in its entirety to read as follows

     “(iii) The Borrower hereby unconditionally promises to pay to the Swingline Lender the
then unpaid principal amount of each Swingline Loan (x) if made on any date prior to the
Tranche 1 Revolving Credit Commitment Termination Date, on the earlier of the Tranche 1
Revolving Credit Commitment Termination Date and the first date after such Swingline Loan is
made that is the 15th or last day of a calendar month and is at least two Business Days
after such Swingline Loan is made and (y) if made on or after the Tranche 1 Revolving Credit
Commitment Termination Date, on the earlier of the Tranche 2 Revolving Credit Commitment
Termination Date and the first date after such Swingline Loan is made that is the 15th or
last day of a calendar month and is at least two Business Days after such Swingline Loan is
made; provided that on each date that a Syndicated Revolving Credit Borrowing or
Competitive Borrowing is made, the Borrower shall repay all Swingline Loans then
outstanding.”

 

- 16 -

          C. Section 2.10(a)(iv) shall be amended and restated in its entirety to read as follows:

     “(iv) (A) The Borrower hereby unconditionally promises to pay to the Administrative
Agent for account of each Tranche 1 Term Lender the outstanding principal amount of the
Tranche 1 Term Loans held by such Tranche 1 Term Lender on the Tranche 1 Term Loan Maturity
Date.

     (B) The Borrower hereby unconditionally promises to pay to the Administrative Agent
for account of each Tranche 2 Term Lender the principal amount of the Tranche 2 Term Loans
held by such Tranche 2 Term Lender in 8 consecutive quarterly installments payable on the
Tranche 2 Term Loan Principal Payment Dates, the aggregate principal amount to be paid on
each Tranche 2 Principal Payment Date in respect of all Tranche 2 Term Loans held by the
Tranche 2 Term Lenders to be in an amount equal to the percentage specified below of the
aggregate original principal amount of the Tranche 2 Term Loans outstanding as of (and after
giving effect to) Amendment No. 3 Effective Date (with the final such installment on the
Tranche 2 Term Loan Maturity Date being in the aggregate principal amount of Tranche 2 Term
Loans then outstanding):

	 	 	 	 	 
	Tranche 2 Principal Payment Date	 	Percentage of Original
	Falling on or Nearest to:	 	Principal Amount
	December 31, 2012
	 	 	2.5	%
	 
	 	 	 	 
	March 31, 2013
	 	 	2.5	%
	June 30, 2013
	 	 	2.5	%
	September 30, 2013
	 	 	2.5	%
	December 31, 2013
	 	 	2.5	%
	 
	 	 	 	 
	March 31, 2014
	 	 	2.5	%
	June 30, 2014
	 	 	2.5	%
	Tranche 2 Term Loan Maturity Date
	 	Balance.	 

     (C) The Borrower hereby unconditionally promises to pay to the Administrative Agent
for account of each Incremental Term Lender the principal amount of each Incremental Term
Loan held by such Incremental Term Lender on the relevant principal payment dates and in
such amounts as shall have been agreed pursuant to Section 2.20 (with the final payment
thereof to be made on the final maturity date thereof as so agreed); provided that,
if such Incremental Term Loan shall be treated as a Tranche 2 Term Loan pursuant to Section
2.20, such Incremental Term Loan shall be paid in accordance with sub-clause (B) above and
the aggregate amount of the principal installments required thereunder shall be adjusted for
the amount of such Incremental Term Loan at the time made.”

     D. Section 2.10(b) shall be amended and restated in its entirety to read as follows:

     “(b) Adjustment of Term Loan Amortization Schedules. Any optional prepayment
of Term Loans pursuant to Section 2.11(a) shall be applied ratably to all then outstanding
Term Loans and, with respect to the principal installments of each tranche of Term Loans, in
the order determined in accordance with Section 2.11(a). Any mandatory prepayment of the
Term Loans pursuant to Section 2.11(b) shall be applied ratably to all then outstanding Term
Loans and, in the case of each tranche of Term Loans, in the order specified in Section
2.11(b).”

 

- 17 -

          2.11. Prepayment of Loans. Section 2.11 of the Credit Agreement shall be amended as
follows:

          A. Section 2.11(b) shall be amended by inserting a new paragraph (v), immediately after
paragraph (iv), to read as follows:

     “(v) If after the Amendment No. 3 Effective Date a Qualifying Convertible Notes
Payment shall occur, an amount equal to the Relevant Share of the Qualifying Convertible
Notes Payment Amount shall be applied on each Relevant Application Date towards the
prepayment of the Term Loans as set forth in Section 2.11(b)(iv); provided that, if
at any time on or after the Amendment No. 3 Effective Date either (A) all of the outstanding
Senior Notes have been paid or prepaid in full or (B) all of the outstanding Senior Notes
(and the related Senior Note Purchase Agreements) shall have been amended to delete the
provision corresponding to this clause (v), then, effective upon written notice by the
Borrower to the Administrative Agent of such payment or prepayment or upon receipt by the
Administrative Agent of a signed copy of such amendment(s) reasonably acceptable to the
Administrative Agent, as applicable, this Section 2.11(b)(v) shall automatically cease to be
in effect.”

          B. A new Section 2.11(e), immediately after Section 2.11(d), to read as follows:

     “(e) Treatment of Tranches. Notwithstanding anything herein to the contrary,
(i) at any time prior to the Tranche 1 Revolving Credit Commitment Termination Date and the
repayment in full of all Tranche 1 Revolving Credit Loans, with respect to any optional or
mandatory prepayment of Revolving Credit Loans under this Section, such prepayment shall be
applied ratably between the Tranche 1 Revolving Credit Loans and the Tranche 2 Revolving
Credit Loans and (ii) with respect to any optional or mandatory prepayment of Term Loans
under this Section, such prepayment shall be applied ratably between the Tranche 1 Term
Loans and the other Term Loans.”

          2.12. Fees.

          A. Section 2.12(a) of the Credit Agreement shall be amended and restated in its entirety to
read as follows:

     “(a) Commitment Fee. The Borrower agrees to pay to the Administrative Agent
for account of each Revolving Credit Lender a commitment fee, which shall accrue at the
Applicable Rate on the average daily unused amount of the Revolving Credit Commitment of any
Tranche of such Revolving Credit Lender during the period from and including the Effective
Date to but excluding the earlier of the date the Revolving Credit Commitments of such
Tranche terminate and the Revolving Credit Commitment Termination Date of such Tranche.
Accrued commitment fees shall be payable on each Quarterly Date and on the earlier of the
date the Revolving Credit Commitments of the applicable Tranche terminate and the Revolving
Credit Commitment Termination Date of such Tranche, commencing on the first such date to
occur after the date hereof. All commitment fees shall be computed on the basis of a year
of 360 days and shall be payable for the actual number of days elapsed (including the first
day but excluding the last day). For purposes of computing commitment fees, the Revolving
Credit Commitment of any Tranche of a Revolving Credit Lender shall be deemed to be used to
the extent of the outstanding Revolving Credit Loans and LC Exposure of such Revolving
Credit Lender (and the Swingline Exposure of such Revolving Credit Lender shall be
disregarded for such purpose).”

 

- 18 -

          B. Section 2.12(b) of the Credit Agreement shall be amended and restated in its entirety to
read as follows:

     “(b) Letter of Credit Fees. The Borrower agrees to pay (i) to the
Administrative Agent for account of each Revolving Credit Lender a participation fee with
respect to the portion of the LC Exposure of such Revolving Credit Lender attributable to
its Revolving Credit Commitments of any Tranche, which shall accrue at a rate per annum
equal to the Applicable Rate applicable to interest on Syndicated Eurocurrency Revolving
Credit Loans of such Tranche on the average daily amount of such Revolving Credit Lender’s
LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements)
during the period from and including the Effective Date to but excluding the later of the
date on which such Revolving Credit Lender’s Revolving Credit Commitment of such Tranche
terminates and the date on which such Revolving Credit Lender ceases to have any LC
Exposure, and (ii) to the respective Issuing Lender a fronting fee, which shall accrue at
the rate or rates per annum separately agreed upon between the Borrower and such Issuing
Lender on the average daily amount of the LC Exposure (excluding any portion thereof
attributable to unreimbursed LC Disbursements) in respect of Letters of Credit issued by
such Issuing Lender during the period from and including the Effective Date to but excluding
the later of the date of termination of the Revolving Credit Commitments and the date on
which there ceases to be any LC Exposure, as well as such Issuing Lender’s standard fees
with respect to the issuance, amendment, renewal or extension of any Letter of Credit or
processing of drawings thereunder. Participation fees and fronting fees shall be payable
quarterly in arrears on the applicable Quarterly Date, commencing on the first such date to
occur after the Effective Date; provided that all such fees attributable to
Revolving Credit Commitments of any Tranche shall be payable on the date on which such
Revolving Credit Commitments terminate and any such fees accruing after the date on which
such Revolving Credit Commitments terminate shall be payable on demand. Any other fees
payable to any Issuing Lender pursuant to this paragraph shall be payable within 10 days
after demand. All participation fees and fronting fees shall be computed on the basis of a
year of 360 days and shall be payable for the actual number of days elapsed (including the
first day but excluding the last day).”

          C. Section 2.12 of the Credit Agreement shall be amended by inserting a new paragraph (e) at
the end thereof to read as follows:

     “(e) Additional Fees. Prior to the Tranche 1 Revolving Credit Commitment
Termination Date, to the extent the Applicable Rate for commitment fees payable for any
period under paragraph (a) of this Section to the Tranche 2 Revolving Credit Lenders shall
exceed the Applicable Rate for commitment fees payable for such period thereunder to the
Tranche 1 Revolving Credit Lenders, (i) for purposes of such paragraph (a), the commitment
fees payable for such period thereunder to all Revolving Credit Lenders shall be calculated
and paid at the Applicable Rate applicable to the Tranche 1 Revolving Credit Lenders and
(ii) the Borrower agrees to pay to the Tranche 2 Revolving Credit Lenders additional fees
from time to time in consideration of the agreements of the Tranche 2 Revolving Credit
Lenders under Amendment No. 3 for such period equal to (A) the difference between the
commitment fees that would have payable for such period to the Tranche 2 Revolving Credit
Lenders under such paragraph (a) had such fees been calculated at the Applicable Rate for
the Tranche 2 Revolving Credit Lenders (without regard to clause (i) above) and (B) the
commitment fees payable to the Tranche 2 Revolving Credit Lenders for such period under such
clause (i) (which fees shall payable at the same times as the fees payable under such clause
(i) and calculated on the same basis).”

          2.13. Interest. Section 2.13 of the Credit Agreement shall be amended as follows:

 

- 19 -

          A. Section 2.13(a) shall be amended by inserting at the end thereof, immediately prior to the
period, the following words:

“; provided that, for purposes hereof, from and after the Amendment No. 3 Effective
Date, Swingline Loans shall bear interest at the Applicable Rate for ABR Borrowings under
the Tranche 2 Revolving Credit Commitments”.

          B. Section 2.13(d) shall be amended by inserting in the last line thereof, immediately after
the words “ABR Loans”, the words “of any Tranche”.

          C. Section 2.13(e) shall be amended and restated in its entirety to read as follows:

     “(e) Payment of Interest. Accrued interest on each Loan shall be payable in
arrears on each Interest Payment Date for such Loan and, in the case of Syndicated Revolving
Credit Loans of any Tranche, upon termination of the Revolving Credit Commitments of such
Tranche; provided that (i) interest accrued pursuant to paragraph (d) of this
Section shall be payable on demand, (ii) in the event of any repayment or prepayment of any
Loan (other than a prepayment of a Syndicated ABR Revolving Credit Loan prior to the
applicable Revolving Credit Commitment Termination Date), accrued interest on the principal
amount repaid or prepaid shall be payable on the date of such repayment or prepayment and
(iii) in the event of any conversion of any Syndicated Eurocurrency Borrowing denominated in
Dollars prior to the end of the Interest Period therefor, accrued interest on such Borrowing
shall be payable on the effective date of such conversion.”.

          2.14. Payments. Section 2.18(f) of the Credit Agreement shall be amended and
restated in its entirety to read as follows:

     “(f) Certain Deductions by the Administrative Agent. If any Lender shall fail
to make any payment required to be made by it pursuant to Section 2.05(c), 2.06(e), 2.06(f),
2.07(b), 2.18(d) or 9.03(c), then the Administrative Agent may, in its discretion and
notwithstanding any contrary provision hereof, (i) apply any amounts thereafter received by
the Administrative Agent for the account of such Lender and for the benefit of the
Administrative Agent, the Swingline Lender or any Issuing Lender to satisfy such Lender’s
obligations to it under such Sections until all such unsatisfied obligations are fully paid,
and/or (ii) hold any such amounts in a segregated account as cash collateral for, and
application to, any future funding obligations of such Lender under such Sections; in the
case of each of (i) and (ii) above, in any order as determined by the Administrative Agent
in its discretion.”

          2.15. Incremental Commitments and Loans. A new Section 2.20 of the Credit Agreement
shall be inserted, immediately following Section 2.19 of the Credit Agreement, to read as follows
(and the Table of Contents of the Credit Agreement will be deemed amended to refer to such new
Section):

     “SECTION 2.20. Incremental Commitments and Loans. The Borrower may, at any
time after the Amendment No. 3 Effective Date by notice to the Administrative Agent,
request:

     (a) one or more increases in the aggregate amount of the Tranche 2 Revolving Credit
Commitments hereunder by (i) having an existing Tranche 2 Revolving Credit Lender increase
the amount of its Tranche 2 Revolving Credit Commitment then in effect and/or (ii) adding as
a new Tranche 2 Revolving Credit Lender with a new Dollar Revolving Credit Sub-Commitment or
Multicurrency Revolving Sub-Commitment hereunder any Person which is not then a Dollar

 

- 20 -

Revolving Credit Lender or a Multicurrency Revolving Credit Lender, as applicable (each
such Lender or Person, an “Incremental Revolving Credit Lender”; and each such
increase by an Incremental Revolving Credit Lender, an “Incremental Revolving Credit
Commitment”); or

     (b) one or more additional tranches of term loans in Dollars hereunder by having an
existing Term Lender or any other Person provide such additional term loan (each such Lender
or Person, an “Incremental Term Lender” and, together with an Incremental Revolving
Credit Lender, each an “Incremental Lender”; each such additional term loan by an
Incremental Term Lender, an “Incremental Term Loan” and the commitment of an
Incremental Term Lender to provide an Incremental Term Loan, an “Incremental Term Loan
Commitment”);

which notice shall specify the name of each proposed Incremental Lender, the amount of such
Incremental Lender’s Incremental Revolving Credit Commitment (and whether such increase is
in respect of the Dollar Revolving Credit Sub-Commitment or the Multicurrency Revolving
Credit Sub-Commitment) or Incremental Term Loan Commitment, as applicable, the date on which
such Commitment shall be effective (the “Incremental Loan Effective Date”) (which
shall be a Business Day at least three Business Days after delivery of such notice and 30
days prior to (x) in respect of an Incremental Revolving Credit Commitment, the Tranche 2
Revolving Credit Commitment Termination Date or (y) in respect of an Incremental Term Loan
Commitment, the Tranche 2 Term Loan Maturity Date); provided that each such
Incremental Lender shall be subject to the prior written consent of the Administrative Agent
(such consent not to be unreasonably withheld) if such consent would be required under
Section 9.04(b) for an assignment of Revolving Credit Commitments or Term Loans, as
applicable, to such Incremental Lender; and provided, further, that:

     (i) the aggregate amount of Incremental Revolving Credit Commitments and
Incremental Term Loan Commitments under this Section shall not exceed $200,000,000;

     (ii) the minimum amount of any Incremental Revolving Credit Commitment or
Incremental Term Loan Commitment shall be $10,000,000 or a larger multiple of
$1,000,000;

     (iii) both at the time of any such request and as of the relevant Incremental
Loan Effective Date, no Default or Event of Default shall have occurred and be
continuing or would result therefrom;

     (iv) the representations and warranties of the Borrower set forth in this
Agreement, and of each Loan Party in each of the other Loan Documents to which it is
a party, shall be true and correct in all material respects on and as of the
relevant Incremental Loan Effective Date (or, if any such representation or warranty
is expressly stated to have been made as of a specific date, as of such date);

     (v) each Incremental Revolving Credit Commitment shall be a Tranche 2
Revolving Credit Commitment for all purposes of this Agreement having the same terms
applicable to the then existing Tranche 2 Revolving Credit Commitments; and

     (vi) (x) except as to interest rates, amortization and final maturity date
(which shall, subject to subclauses (y) and (z) below, be determined by the Borrower
and the Incremental Term Lenders in their sole discretion, with, in the case of the
final maturity date only, the consent of the Administrative Agent (such consent not
to be unreasonably withheld)), the Incremental Term Loans shall have the same terms
as the then existing

 

- 21 -

Tranche 2 Term Loans, (y) the final maturity date of any Incremental Term Loan
shall be no earlier that the Tranche 2 Term Loan Maturity Date and (z) the weighted
average life to maturity of any Incremental Term Loan shall be no shorter than the
remaining weighted average life to maturity of the Tranche 2 Term Loans;
provided that if any Incremental Term Loan shall have the same interest
rate, amortization and final maturity date as the existing Tranche 2 Term Loans at
the time such Incremental Term Loan is made, such Incremental Term Loan shall be
treated as a Tranche 2 Term Loan for all purposes of this Agreement.

     Each Incremental Revolving Credit Commitment (and the increase of, or the undertaking
of, any Revolving Credit Sub-Commitment of each Incremental Revolving Credit Lender
resulting therefrom) or each Incremental Term Loan Commitment, as the case may be, shall
become effective as of the relevant Incremental Loan Effective Date upon receipt by the
Administrative Agent, on or prior to 11:00 a.m., New York City time, on such Incremental
Loan Effective Date, of (A) a certificate of a duly authorized officer of the Borrower
stating that the conditions with respect to such Incremental Revolving Credit Commitment or
Incremental Term Loan Commitment, as applicable, under this paragraph have been satisfied
and (B) an agreement, in form and substance reasonably satisfactory to the Borrower and the
Administrative Agent, which shall provide for such Incremental Revolving Credit Commitment
and/or Incremental Term Loan Commitment of each Incremental Lender and the other relevant
terms relating thereto, duly executed by each Incremental Lender and the Borrower and
acknowledged by the Administrative Agent, and customary legal opinions or other documents
reasonably requested by the Administrative Agent in connection therewith.

     With respect to any Incremental Revolving Credit Commitment or Incremental Term Loan
Commitment, upon the Administrative Agent’s receipt of each such agreement executed by such
parties, together with the other documentation contemplated above, and subject to the
foregoing terms and conditions, on the relevant Loan Effective Date each Incremental Lender
shall become a Lender hereunder with an Incremental Revolving Credit Commitment or
Incremental Term Loan Commitment, as applicable, and the Administrative Agent shall record
the information contained in such agreement in the Register and give prompt notice thereof
to the Borrower and the Lenders.

     On the Incremental Loan Effective Date for an Incremental Revolving Credit Commitment,
(i) in the event Syndicated Revolving Credit Loans are then outstanding under the Revolving
Credit Sub-Commitment of any Tranche that is being increased, (x) each relevant Incremental
Revolving Credit Lender shall make available to the Administrative Agent such amounts in
immediately available funds as the Administrative Agent shall determine, for the benefit of
the other relevant Revolving Credit Lenders under such Revolving Credit Sub-Commitment of
such Tranche, as being required in order to cause, after giving effect to such increase and
the application of such amounts to make payments to such other Revolving Credit Lenders, the
Syndicated Revolving Credit Loans to be held ratably by all Revolving Credit Lenders under
such Revolving Credit Sub-Commitment of such Tranche in accordance with their respective
Revolving Credit Sub-Commitments of such Tranche, (y) the Borrower shall be deemed to have
prepaid and reborrowed all outstanding Syndicated Revolving Credit Loans under such
Revolving Credit Sub-Commitment of such Tranche as of such Incremental Loan Effective Date
(with such borrowing to consist of the Type of Revolving Credit Loans, with related Interest
Periods if applicable, specified in a notice delivered by the Borrower in accordance with
the requirements of Section 2.03) and (z) the Borrower shall pay to the Revolving Credit
Lenders under such Revolving Credit Sub-Commitment of such Tranche the amounts, if any,
payable under Section 2.14 as a result of such prepayment; and (ii) the

 

- 22 -

participations hereunder in Swingline Loans and/or Letters of Credit then outstanding
held by the Revolving Credit Lenders shall be adjusted accordingly to reflect the addition
of such Incremental Revolving Credit Commitment.

     On the Incremental Loan Effective Date (or such other date provided above for in the
relevant agreement referred to above) for an Incremental Term Loan Commitment, each relevant
Incremental Term Lender shall make an Incremental Term Loan to the Borrower in the amount of
such Incremental Term Loan Commitment pursuant to this Section and otherwise in accordance
with this Agreement; provided that, if such Incremental Term Loan shall be treated
as a Tranche 2 Term Loan pursuant to clause (vi) above, such Incremental Term Loan shall
consist proportionately of the same Type of Term Loans as the then outstanding Tranche 2
Term Loans and, in the case of Eurocurrency Term Loans, having an Interest Period or
Interest Periods ending on the last day(s) of the Interest Period(s) for such outstanding
Tranche 2 Term Loans.

     Notwithstanding anything herein to the contrary, in no event shall any Lender be
obligated to increase its Commitment hereunder.”

          2.16. Use of Loan Proceeds and Letters of Credit. Section 5.08 of the Credit
Agreement shall be amended and restated in its entirety to read as follows:

     “SECTION 5.08. Use of Loan Proceeds and Letters of Credit. The proceeds of
the Revolving Credit Loans, any New Tranche 2 Term Loans made on the Amendment No. 3
Effective Date and any Incremental Loans will be used for general corporate purposes of the
Borrower and its Subsidiaries, including, in the case of Borrowings as of the Amendment No.
3 Effective Date, to pay fees, expenses and other amounts owing by the Borrower in respect
of Amendment No. 3 and the transactions contemplated thereby occurring as of the Amendment
No. 3 Effective Date. No part of the proceeds of any Loan will be used, whether directly or
indirectly, for any purpose that entails a violation of any of the regulations of the Board,
including Regulations U and X. The Letters of Credit will be used in the ordinary course of
business of the Borrower and its Subsidiaries.”

          2.17. Indebtedness. Section 6.01 of the Credit Agreement shall be amended as
follows:

          A. Section 6.01(i) shall be amended and restated in its entirety to read as follows:

     “(i) Indebtedness in respect of a convertible notes offering by the Borrower
(including the convertible notes issued as of the Amendment No. 3 Effective Date, as
contemplated by Section 4.02(b) of Amendment No. 3); provided that (i) such
Indebtedness does not provide for any scheduled repayment, mandatory redemption or sinking
fund obligation prior to one year after the Tranche 2 Term Loan Maturity Date and (ii) such
Indebtedness is (x) unsecured and (y) subordinated in right of payment to the Obligations on
terms substantially similar to the subordination terms contained in the convertible notes
issued as of the Amendment No. 3 Effective Date; provided, however, that (I)
any conversion of such Indebtedness by a holder thereof into shares of Equity Interests,
cash or a combination of cash and shares of Equity Interests, (II) the rights of holders of
such Indebtedness to convert into shares of Equity Interests, cash or a combination of cash
and shares of Equity Interests and (III) the rights of holders of such Indebtedness to
require any repurchase by the Borrower upon a fundamental change of such Indebtedness in
cash, shall not constitute a scheduled repayment, mandatory redemption or sinking fund
obligation;”.

          B. Section 6.01(j) shall be amended and restated in its entirety to read as follows:

 

- 23 -

     “(j) other Indebtedness in an aggregate principal amount not to exceed 25% of
Consolidated Net Worth; provided that, if at any time on or after the Amendment No.
3 Effective Date either (i) all of the outstanding Senior Notes have been paid or prepaid in
full or (ii) all of the outstanding Senior Notes (and the related Senior Note Purchase
Agreements) shall have been amended to provide that the basket thereunder corresponding to
this clause (j) shall be an incurrence-based basket, then, effective upon written notice by
the Borrower to the Administrative Agent of such payment or prepayment or upon receipt by
the Administrative Agent of a signed copy of such amendment(s) reasonably acceptable to the
Administrative Agent, as applicable, this clause (j) shall automatically be deemed amended
to permit other Indebtedness if, at the time of the creation, incurrence or assumption of
such Indebtedness, the principal amount of such Indebtedness, together with the then
aggregate outstanding principal amount of other Indebtedness theretofore created, incurred,
assumed under this clause (j), would not exceed 25% of Consolidated Net Worth as of the end
of the then most recent fiscal quarter for which financial statements are available; and”.

          C. A new Section 6.01(k) shall be inserted at the end of Section 6.01, immediately after
clause (j) thereof, to read as follows:

     “(k) unsecured, senior subordinated or subordinated notes of the Borrower (and any
unsecured, subordinated Guarantees thereof by the Guarantors) in an aggregate principal
amount not to exceed $200,000,000 at any time outstanding.”

          2.18. Acquisitions. Section 6.05(h) of the Credit Agreement shall be amended and
restated in its entirety to read as follows:

     “(h) any Acquisition after the date hereof by the Borrower or any Subsidiary;
provided that (i) in the case of any such Acquisition, (x) if the Acquired Entity is
a publicly held corporation, such Acquisition shall have been approved by the board of
directors of such Acquired Entity; (y) after giving effect to any such Acquisition of Equity
Interests, the Acquired Entity becomes a direct or indirect Subsidiary of the Borrower; and
(z) the Acquired Entity is engaged in a line of business in accordance with the requirements
of Section 6.10; (ii) both immediately prior to such Acquisition and after giving effect
thereto, no Default shall have occurred and be continuing; and (iii) if, after giving effect
to such Acquisition on a pro forma basis as if such Acquisition had occurred on the first
day of the most recent period of four consecutive fiscal quarters of the Borrower, the
Consolidated Leverage Ratio shall be greater than 3.50 to 1.00, the aggregate consideration
(including assumed Indebtedness, but excluding consideration in the form of the Equity
Interests of the Borrower) for all such Acquisitions shall not exceed $150,000,000 in any
fiscal year; provided that, if any time on or after the Amendment No. 3 Effective
Date either (A) all of the outstanding Senior Notes have been paid or prepaid in full or (B)
all of the outstanding Senior Notes (and the related Senior Note Purchase Agreements) shall
have been amended to increase the maximum permitted leverage ratio applicable under the
covenant contained in such Senior Notes corresponding to this subclause (iii) to a level
above 3.50 to 1.00, then, effective upon written notice by the Borrower to the
Administrative Agent of such payment or prepayment or upon receipt by the Administrative
Agent of a signed copy of such amendment(s) reasonably acceptable to the Administrative
Agent, as applicable, the ratio set forth above in this subclause (iii) shall automatically
be deemed amended to be (x) in the case of subclause (A) above, 3.75 to 1.0 or (y) in the
case of subclause (B) above, the same level as such ratio in such Senior Notes as so amended
(but in no event greater than 3.75 to 1.0).

 

- 24 -

          2.19. Restrictive Payments. Section 6.06 of the Credit Agreement shall be amended by
inserting at the end of clause (b)(ii) thereof, immediately after the semi-colon, the following
words:

“provided that that this clause (b)(ii) shall not apply to any Restricted Payment
made in connection with any hedge transactions, warrant transactions and capped call
transactions in respect of Convertible Notes;”.

          2.20. Restrictive Agreements. Section 6.08 of the Credit Agreement shall be amended
as follows:

          A. The word “and” shall be deleted at the end of clause (v) of Section 6.08 and the period at
the end of clause (vi) thereof shall be replaced with “; and”.

          B. A new clause (vii) shall be inserted in Section 6.08, immediately after clause (vi)
thereof, to read as follows:

     “(vii) restrictions or conditions imposed by any agreement relating to Indebtedness
permitted by Section 6.01, if such restrictions or conditions are customary for such
Indebtedness.”

          2.21. Financial Covenants. Section 6.09 of the Credit Agreement shall be amended and
restated in its entirety to read as follows:

     “SECTION 6.09. Certain Financial Covenants.

     (a) Leverage Ratio. The Borrower will not permit the Consolidated Leverage
Ratio, as at the last day of any period of four consecutive fiscal quarters of the Borrower,
to exceed 3.50 to 1.0; provided that, if any time on or after the Amendment No. 3
Effective Date either (i) all of the outstanding Senior Notes have been paid or prepaid in
full or (ii) all of the outstanding Senior Notes (and the related Senior Note Purchase
Agreements) shall have been amended to increase the maximum permitted leverage ratio
applicable under the covenant contained in such Senior Notes corresponding to this clause
(a) to a level above 3.50 to 1.00, then, effective upon written notice by the Borrower to
the Administrative Agent of such payment or prepayment or upon receipt by the Administrative
Agent of a signed copy of such amendment(s) reasonably acceptable to the Administrative
Agent, as applicable, the ratio set forth above in this clause (a) shall automatically be
deemed amended to be (A) in the case of subclause (i) above, 4.00 to 1.0 or (B) in the case
of subclause (ii) above, the same level as such ratio in such Senior Notes as so amended
(but in no event greater than 4.00 to 1.0).

     (b) Interest Coverage Ratio. The Borrower will not permit the Consolidated
Interest Coverage Ratio for any period of four consecutive fiscal quarters of the Borrower
to be less than 3.50 to 1.0.”

 

- 25 -

          2.22. Swap Agreements. Section 6.11 of the Credit Agreement shall be amended by
inserting at the end thereof, immediately prior to the period, the following words:

“(including, among other Swap Agreements, hedge transactions, warrant transactions and
capped call transactions in respect of Convertible Notes)”.

          2.23. Events of Default. Article VII of the Credit Agreement shall be amended by
inserting at the end of clause (g) thereof, immediately prior to the semi-colon, the following
words:

“; provided, further, that, in connection with any Convertible Notes, (i)
any conversion of such Indebtedness by a holder thereof into shares of Equity Interests,
cash or a combination of cash and shares of Equity Interests, (ii) the rights of holders of
such Indebtedness to convert into shares of Equity Interests, cash or a combination of cash
and shares of Equity Interests, (iii) the rights of holders of such Indebtedness to require
any repurchase by the Borrower upon a fundamental change of such Indebtedness in cash and
(iv) the termination of any of Swap Agreements entered into in connection with a convertible
note offering, shall not constitute an Event of Default under this clause (g) or clause (f)
above”.

          2.24. Assignments. Section 9.04(b) of the Credit Agreement shall be amended by
deleting, in clause (i)(B)(ii) thereof, the words “Term Loan Commitments and”.

          2.25. Schedules. Schedule 2.01 of the Credit Agreement shall be amended and replaced
in its entirety by Schedule 2.01 attached to this Amendment.

          Section 3. Representations and Warranties. The Borrower represents and warrants to
the Administrative Agent and the Lenders that, as of each of the Convertible Notes Amendments
Effective Date (with respect to clauses (a) and (b) below only) and the Amendment No. 3 Effective
Date, (a) the representations and warranties of the Borrower set forth in the Credit Agreement as
amended hereby, and of each Loan Party in each of the other Loan Documents to which it is a party,
are true and correct in all material respects on and as of such date (or, if any such
representation or warranty is expressly stated to have been made as of a specific date, as of such
specific date); (b) no Default shall have occurred and be continuing under the Credit Agreement as
amended hereby; (c) the value of the guarantees of the Released Subsidiaries, taken as a whole,
that are being released pursuant to Section 6 of this Amendment is not all or substantially all of
the value of the guarantees of the Guarantors under Article X of the Credit Agreement; and (d) the
value of the collateral of the Released Subsidiaries, taken as a whole, that is being released and
terminated pursuant to Section 6 of this Amendment is not all or substantially all of the
collateral under the Security Documents.

          Section 4. Conditions to Effectiveness of Amendments.

          4.01. Conditions to Certain Amendments. The amendments set forth in Sections 2.01,
2.02 (but only with respect to the addition of the definition of “Convertible Notes” contained
therein), 2.17A, 2.19, 2.20, 2.22 and 2.23 of this Amendment (collectively, the “Convertible
Notes Amendments”) shall become effective on the date on which the Administrative Agent shall
have received each of the following, each of which shall be reasonably satisfactory in form and
substance to the Administrative Agent (or such condition shall have been waived by the Required
Lenders) (such date, the “Convertible Notes Amendments Effective Date”):

     (a) Executed Counterparts. Counterparts of this Amendment signed on behalf of
each of the Borrower, each Guarantor, the Required Lenders under (and as defined in) the
Credit Agreement, the Administrative Agent and the Syndication Agent; provided that
the parties hereto

 

- 26 -

hereby agree that each Lender which executes and delivers an Amendment No. 3 Lender
Addendum substantially in the form attached hereto shall be deemed to have executed a
counterpart of this Amendment (it being understood that such Required Lenders hereby
consent, and authorize and direct the Administrative Agent and the Syndication Agent to
consent, and pursuant to Section 6.12 of the Credit Agreement the Administrative Agent and
the Syndication Agent hereby consent, to the amendments to the Senior Notes, which are in
substantially the same form as the amendments furnished to the Lenders prior to the
Convertible Notes Amendments Effective Date); and

     (b) Amendments to Senior Notes. Evidence that the Senior Notes shall have
been amended to effect changes consistent with the Convertible Notes Amendments, among other
changes, and such amendments shall have become effective prior to or simultaneously with the
Convertible Notes Amendments Effective Date.

          4.02 Conditions to Amendment No. 3 Effective Date. The amendments set forth in
Section 2 hereof (other than the Convertible Notes Amendments) shall not become effective until the
date (which shall be no later than September 30, 2010) on which the Administrative Agent shall have
received each of the following, each of which shall be reasonably satisfactory in form and
substance to the Administrative Agent (or such condition shall have been waived by the Required
Lenders):

     (a) Executed Counterparts. Counterparts of this Amendment signed on behalf
of, in addition to the parties referred to in Section 4.01(a) hereof, the Administrative
Agent, the Issuing Lenders, the Swingline Lender, each Tranche 2 Revolving Credit Lender
(including each New Tranche 2 Revolving Credit Lender) and each Tranche 2 Term Lender
(including each New Tranche 2 Term Lender); provided that the parties hereto hereby
agree that each Tranche 2 Revolving Credit Lender (including each New Tranche 2 Revolving
Credit Lender) and each Tranche 2 Term Lender (including each New Tranche 2 Term Lender)
which executes and delivers an Amendment No. 3 Lender Addendum substantially in the form
attached hereto shall be deemed to have executed and delivered a counterpart of this
Amendment (and, in the case of each New Tranche 2 Revolving Credit Lender and each New
Tranche 2 Term Lender, as of the Amendment No. 3 Effective Date, such Lender shall become a
Lender party to the Credit Agreement as amended hereby with its respective New Tranche 2
Revolving Credit Commitment or New Tranche 2 Term Loan Commitment, as applicable);
provided, further, that the aggregate amount of the Tranche 2 Revolving
Credit Commitments (including New Tranche 2 Revolving Credit Commitments) as of the
Amendment No. 3 Effective Date shall not exceed $400,000,000.

     (b) Convertible Notes. Evidence that the Borrower shall have received the
gross proceeds from the issuance of Convertible Notes of not less than $325,000,000.

     (c) Outstanding Credit Exposure; Repayment of Term Loans. Evidence that, as
of the Amendment No. 3 Effective Date, (i) all unpaid accrued interest on outstanding Loans
shall have been paid in full; (ii) all unpaid commitment fees in respect of the Revolving
Credit Commitments in effect immediately prior to the Amendment No. 3 Effective Date and all
letter of credit fees, accrued to but not including the Amendment No. 3 Effective Date,
shall have been paid in full; and (iii) the Borrower shall have prepaid the Term Loans
outstanding under the Credit Agreement immediately prior to the Amendment No. 3 Effective
Date (the “Existing Term Loans”) (for avoidance of doubt, exclusive of any New
Tranche 2 Term Loans made as of the Amendment No. 3 Effective Date pursuant to the second
sentence of Section 2.01(b) of the Credit Agreement as amended hereby), together with
(without duplication) interest thereon, such that, after giving effect to such prepayment,
the portion of the Term Loans consisting of Existing Term Loans outstanding as of the
Amendment No. 3 Effective Date shall not exceed $400,000,000 in

 

- 27 -

aggregate principal amount (provided that the Required Lenders hereby waive any
payment of breakage funding amounts that may be payable under Section 2.16 of the Credit
Agreement in connection with such prepayment).

     (d) Opinion of Counsel to the Loan Parties. A favorable written opinion
(addressed to the Administrative Agent and the Lenders and dated the Amendment No. 3
Effective Date) of Simpson Thacher & Bartlett LLP, counsel to the Loan Parties, in form and
substance satisfactory to the Administrative Agent and covering such other matters relating
to the Loan Parties, this Amendment or the transactions contemplated hereby as the
Administrative Agent shall reasonably request (and the Borrower hereby instructs such
counsel to deliver such opinion to the Lenders and the Agents).

     (e) Other Documents. Such documents and certificates as the Administrative
Agent or its counsel may reasonably request relating to the organization, existence and good
standing of each Loan Party, the authorization of the transactions contemplated by this
Amendment and any other legal matters relating to the Loan Parties (other than the Released
Subsidiaries) or the transactions contemplated by this Amendment, all in form and substance
reasonably satisfactory to the Administrative Agent and its counsel.

     (f) Fees and Expenses. Evidence that (i) the Administrative Agent shall have
received payment from the Borrower, for the account of each Tranche 2 Revolving Credit
Lender and each Tranche 2 Term Lender, an upfront fee in an amount equal to 0.40% of (x) in
the case of each Tranche 2 Revolving Credit Lender, the amount of such Lender’s Tranche 2
Revolving Credit Commitment (including, without duplication, any New Tranche 2 Revolving
Credit Commitment) in effect on the Amendment No. 3 Effective Date and (y) in the case of
each Tranche 2 Term Lender, the amount of such Lender’s (A) Tranche 2 Term Loans outstanding
as the Amendment No. 3 Effective Date (which, for avoidance of doubt, with respect to any
Term Lender under the Credit Agreement as in effect immediately prior to the Amendment No. 3
Effective Date shall not include any portion of the Existing Term Loans of such Term Lender
prepaid in accordance with Section 4.02(c) hereof) and/or (B) (without duplication) New
Tranche 2 Term Loan Credit Commitment in effect on the Amendment No. 3 Effective Date; (ii)
the Administrative Agent shall have received payment from the Borrower, for the account of
the relevant Person(s), all amounts due and payable to the Administrative Agent on or prior
to the Amendment No. 3 Effective Date pursuant to the Credit Agreement and the Loan
Documents including, to the extent invoiced, reimbursement of all out-of-pocket expenses
(including reasonable fees, charges and disbursements of counsel) required to be reimbursed
or paid by the Borrower thereunder; and (iii) (without duplication) the Administrative Agent
and each of J.P. Morgan Securities Inc. and Banc of America Securities LLC, as the Lead
Arrangers in respect of this Amendment, and their respective Affiliates shall have received
payment from the Borrower all fees, out-of-pocket expenses and other amounts separately
agreed to be paid or reimbursed by the Borrower in connection with this Amendment.

     (g) Convertible Notes Amendments Effective Date. The Convertible Notes
Amendments Effective Date shall have occurred.

          Section 5. Confirmation of Loan Documents. As of each of the Convertible Notes
Amendments Effective Date and the Amendment No. 3 Effective Date, the Borrower hereby confirms and
ratifies all of its obligations under the Loan Documents (in each case, as amended hereby as of
such date) to which it is a party. Except as otherwise provided in Section 6 hereof, by its
execution on the respective signature lines provided below, as of each of the Convertible Notes
Amendments Effective Date and the Amendment No. 3 Effective Date, each of the Guarantors (but
excluding, as of the Amendment No. 3

 

- 28 -

Effective Date, the Released Subsidiaries) hereby confirms and ratifies all of its obligations
(including, without limitation, the obligations as guarantor under Article X of the Credit
Agreement, as amended hereby as of such date) and the Liens granted by it under the Loan Documents
(in each case, as amended hereby as of such date) to which it is a party, represents and warrants
that the representations and warranties set forth in such Loan Documents are complete and correct
in all material respects on the date hereof as if made on and as of such date and confirms that all
references in such Loan Documents to the “Credit Agreement” (or words of similar import) refer to
the Credit Agreement as amended hereby as of such date without impairing any such obligations or
Liens in any respect.

          Section 6. Releases of Certain Guarantees and Pledges of Equity Interests. The
Lenders party to this Amendment hereby agree that, effective upon the Amendment No. 3 Effective
Date (and notwithstanding that the Released Subsidiaries shall have executed this Amendment in
connection with the Convertible Notes Amendments Effective Date), (a) each Released Subsidiary
shall be irrevocably released from any and all of its obligations under the Credit Agreement, the
Security Documents and any other Loan Documents theretofore executed by such Released Subsidiary in
connection with the Credit Agreement, which obligations shall be deemed to be terminated, and (b)
all Liens granted to the Collateral Agent for the benefit of the Secured Parties by each Released
Subsidiary in any or all of its assets and properties shall be unconditionally and irrevocably
terminated and released, in each case without any recourse or warranty or representation
whatsoever. From and after the Amendment No. 3 Effective Date, each Released Subsidiary shall
cease to be party to the Credit Agreement and the other Loan Documents to which such Released
Subsidiary was originally a party and each Released Subsidiary shall have no further rights or
obligations thereunder (except to the extent any such obligations are expressly stated to survive
such release and termination). The Lenders authorize and direct the Collateral Agent to, and the
Collateral Agent shall, as promptly as practicable, in each case, at the expense of the Borrower,
(i) deliver to the Borrower all Collateral relating to or given by each Released Subsidiary in the
possession or control of the Collateral Agent, including, without limitation, all original stock
certificates, membership interests certificates and corresponding stock powers or other instruments
of transfer and instruments constituting, evidencing or relating to such Collateral and (ii) upon
the reasonable request of any Released Subsidiary or the Borrower, execute or authenticate and
deliver such additional lien releases, documents or instruments as may be necessary to evidence the
release, without any recourse or warranty or representation whatsoever, of any and all liens,
pledges, security interests and other encumbrances granted by such Released Subsidiary, in favor of
the Collateral Agent, including without limitation, as applicable, such UCC-3 termination
statements and other documents, as applicable.

          The Lenders party to this Amendment hereby acknowledge and agree as of the Amendment No. 3
Effective Date that if at any time thereafter the Borrower or any of its Subsidiaries shall
transfer the Equity Interests of a First-Tier Foreign Subsidiary that have been pledged pursuant to
the Security Documents to another Foreign Subsidiary in accordance with the Credit Agreement, then,
effective as of such transfer, such pledged Equity Interests shall constitute Excluded Equity
Interests for purposes of the Credit Agreement and the relevant Security Documents and the Liens on
such pledged Equity Interests shall be irrevocably released and terminated. The Lenders authorize
and direct the Collateral Agent to, and the Collateral Agent shall, as promptly as practicable, in
each case, at the expense of the Borrower, deliver to the Borrower, as promptly as practicable
following written notice to the Collateral Agent of such transfer, all original stock certificates,
membership interests certificates and corresponding stock powers or other instruments of transfer
and instruments constituting, evidencing or relating to such pledged Equity Interests in the
possession of the Collateral Agent and, upon the reasonable request of the Borrower, execute or
authenticate and deliver such releases, documents or instruments as may be necessary to evidence
such release and termination, without any recourse or warranty or representation whatsoever.

 

- 29 -

          Section 7. Miscellaneous. Except as herein provided, the Credit Agreement shall
remain unchanged and in full force and effect. The Borrower shall pay all reasonable expenses
incurred by the Administrative Agent, including the reasonable fees, charges and disbursements of
Milbank, Tweed, Hadley & McCloy LLP, special New York counsel to JPMCB, in connection with the
preparation, negotiation, execution and delivery of, and satisfaction of the conditions under, this
Amendment. This Amendment may be executed in any number of counterparts, all of which taken
together shall constitute one and the same agreement and any of the parties hereto may execute this
Amendment by signing any such counterpart. This Amendment shall be governed by, and construed in
accordance with, the law of the State of New York.

[remainder of page intentionally left blank]

 

 

          IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 3 to be duly executed
and delivered as of the day and year first above written.

	 	 	 	 	 
	 	TELEFLEX INCORPORATED

 	 
	 	By:  	\s\ C. Jeffrey Jacobs
 	 
	 	 	Name:  	C. Jeffrey Jacobs 	 
	 	 	Title:  	Treasurer 	 
	 

 

 

	 	 	 	 	 
	 	GUARANTORS

ARROW INTERNATIONAL, INC.
 

ARROW INTERNATIONAL INVESTMENT CORP.
 

ARROW INTERVENTIONAL, INC.
 

SIERRA INTERNATIONAL INC.
 

SPECIALIZED MEDICAL DEVICES, LLC
 

TECHNOLOGY HOLDING COMPANY
 

TELAIR INTERNATIONAL INCORPORATED
 

TELEFLEX MEDICAL INCORPORATED
 

TFX EQUITIES INCORPORATED
 

TFX INTERNATIONAL CORPORATION
 

TFX MARINE INCORPORATED
 

TFX NORTH AMERICA INC.
 

THE STEPIC MEDICAL DISTRIBUTION CORPORATION
 	 
	 	By:  	\s\ C. Jeffrey Jacobs 	 
	 	 	Name:  	C. Jeffrey Jacobs 	 
	 	 	Title:  	(1) Vice President and Treasurer (other than	 
	 	 	for Technology Holding Company, TFX Equities
Incorporated, TFX International Corporation and TFX
North America Inc.)

(2) President and Treasurer (in the case of TFX North
America Inc.)

(3) Vice President (in the case of TFX Equities
Incorporated)

(4) President (in the case of Technology Holding
Company and TFX International Corporation) 	 
	 

 

 

	 	 	 	 	 
	 	ADMINISTRATIVE AGENT

JPMORGAN CHASE BANK, N.A.,

as Administrative Agent

 	 
	 	By:  	\s\ Deborah R. Winkler
 	 
	 	 	Name:  	Deborah R. Winkler 	 
	 	 	Title:  	Vice President 	 
	 

 

 

	 	 	 	 	 
	 	SYNDICATION AGENT

BANK OF AMERICA, N.A.,

as Syndication Agent

 	 
	 	By:  	\s\ Amie L. Edwards
 	 
	 	 	Name:  	Amie L. Edwards 	 
	 	 	Title:  	Senior Vice President 	 
	 

 

 

	 	 	 	 	 
	 	ISSUING LENDERS

JPMORGAN CHASE BANK, N.A.,

as Issuing Lender

 	 
	 	By:  	\s\ Deborah R. Winkler
 	 
	 	 	Name:  	Deborah R. Winkler 	 
	 	 	Title:  	Vice President 	 
	 
	 	WELLS FARGO BANK, N.A.,

SUCCESSOR IN INTEREST BY MERGER TO WACHOVIA BANK, N. A.,

as Issuing Lender

 	 
	 	By:  	\s\ James Trauagline
 	 
	 	 	Name:  	James Trauagline 	 
	 	 	Title:  	Director 	 
	 

 

 

	 	 	 	 	 
	 	SWINGLINE LENDER

JPMORGAN CHASE BANK, N.A.,

as Swingline Lender

 	 
	 	By:  	\s\ Deborah R. Winkler
 	 
	 	 	Name:  	Deborah R. Winkler 	 
	 	 	Title:  	Vice President 	 
	 

 

 

EXHIBIT A

[Form of Amendment No. 3 Lender Addendum]

AMENDMENT NO. 3 LENDER ADDENDUM

          Reference is made to (i) the Credit Agreement dated as of October 1, 2007 (as amended or
otherwise modified, the “Credit Agreement”) between Teleflex Incorporated (the
“Borrower”), the Lenders party thereto (individually, a “Lender” and, collectively,
the “Lenders”), the Guarantors party thereto, JPMorgan Chase Bank, N.A. (“JPMCB”),
as administrative agent (in such capacity, the “Administrative Agent”), JPMCB, as
collateral agent, and Bank of America, N.A., as syndication agent and (ii) Amendment No. 3 dated as
of August 2, 2010 to the Credit Agreement (“Amendment No. 3”). Capitalized terms used and
not otherwise defined herein shall have the meaning assigned thereto in the Credit Agreement, as
amended by Amendment No. 3.

          This is an Amendment No. 3 Lender Addendum (this “Addendum”) referred to in Amendment
No. 3, pursuant to the terms of which, upon execution and delivery of this Addendum by the
undersigned lender (the “Lender Signatory”), the Lender Signatory shall be deemed to have
executed and delivered a counterpart of Amendment No. 3 (and such execution and delivery shall be
irrevocable upon the Convertible Notes Amendment Effective Date).

          By execution and delivery of this Addendum, the Lender Signatory hereby agrees as follows:

          [PLEASE CHECK THE APPROPRIATE BOX OR BOXES UNDER PARTS (I) AND (II) BELOW THAT APPLY TO THE
LENDER SIGNATORY]

          I. EXISTING LENDERS PARTY TO THE CREDIT AGREEMENT

          o FOR EXISTING REVOLVING CREDIT LENDERS: The Lender Signatory, which is a Revolving
Credit Lender under the Credit Agreement, hereby (a) consents to the terms of Amendment No. 3 and
(b) agrees that, effective as of the Amendment No. 3 Effective Date, (i) it shall be a Tranche 2
Revolving Credit Lender for purposes of the Credit Agreement as amended by Amendment No. 3, (ii)
the entire amount of its Revolving Credit Commitment under the Credit Agreement in effect
immediately prior to the Amendment No. 3 Effective Date shall be extended pursuant to Amendment No.
3 and shall be a Tranche 2 Revolving Credit Commitment under the Credit Agreement as so amended and
(iii) the amount of its Tranche 2 Revolving Credit Commitment is as set forth in Schedule 2.01
attached to Amendment No. 3.

          o FOR EXISTING TERM LENDERS: The Lender Signatory, which is a Term Lender under the
Credit Agreement, hereby (a) consents to the terms of Amendment No. 3 and (b) agrees that,
effective as of the Amendment No. 3 Effective Date, (i) it shall be a Tranche 2 Term Lender for
purposes of the Credit Agreement as amended by Amendment No. 3, (ii) the entire amount of its
outstanding Term Loan under the Credit Agreement in effect immediately prior to the Amendment No. 3
Effective Date shall be extended pursuant to Amendment No. 3 and shall be a Tranche 2 Term Loan
under the Credit Agreement as so amended and (iii) the amount of its Tranche 2 Term Loan is as set
forth in Schedule 2.01 attached to Amendment No. 3.

 

 

          II. NEW TRANCHE 2 LENDERS

          [NOTE: BOX BELOW TO BE CHECKED IF LENDER SIGNATORY (WHETHER AN EXISTING LENDER OR A NEW
LENDER) IS PROVIDING A NEW TRANCHE 2 COMMITMENT]

          o The Lender Signatory hereby agrees that, effective as of the Amendment No. 3 Effective
Date, (i) it will provide a New Tranche 2 Revolving Credit Commitment and/or a New Tranche 2 Term
Loan Commitment, as applicable, under the Credit Agreement as amended by Amendment No. 3 in the
amount set forth in Schedule 2.01 attached to Amendment No. 3 (it being understood that allocation
of its new Commitment (but in no event exceeding the total amount of the new commitment committed
by the Lender Signatory in its commitment advice delivered to the Administrative Agent on or prior
to the date hereof on the terms set forth therein) between or to the New Tranche 2 Revolving Credit
Commitments and/or New Tranche 2 Term Loan Commitments under the Credit Agreement as so amended and
the final amount of such allocation(s) will be determined by, and at the discretion of, J.P. Morgan
Securities, Inc, and Bank of America Securities LLC, as Lead Arrangers in respect of Amendment No.
3, in consultation with the Borrower, and listed on such Schedule 2.01) and (ii) (if such Lender
Signatory is not currently a party to the Credit Agreement) it shall become a New Tranche 2
Revolving Credit Lender and/or a New Tranche 2 Term Lender, as applicable, party to the Credit
Agreement as so amended; provided that the Lender Signatory agrees that, upon request of
the Borrower, it will effect such New Tranche 2 Revolving Credit Commitment and/or New Tranche 2
Term Loan Commitment by entering into one or more assignment agreements with one or more existing
Lenders as of the Amendment No. 3 Effective Date. The Lender Signatory (if not a party to the
Credit Agreement in effect immediately prior to the Amendment No. 3 Effective Date) agrees to
deliver to the Administrative Agent an Administrative Questionnaire on or prior to the Amendment
No. 3 Effective Date.

          This Addendum shall be construed in accordance with and governed by the law of the State of
New York. This Addendum may be executed by one or more of the parties hereto on any number of
separate counterparts, and all of such counterparts shall be deemed to constitute one and the same
instrument. Delivery of an executed signature page hereof by facsimile transmission shall be
effective as delivery of a manually executed counterpart hereof.

[remainder of page intentionally blank]

 

 

          IN WITNESS WHEREOF, the parties hereto have caused this Addendum to be duly executed and
delivered by their proper and duly authorized officers as of the date of Amendment No. 3.

	 	 	 	 	 
	Dated as of August 2, 2010 	NAME OF LENDER:

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

 

Accepted and agreed:

TELEFLEX INCORPORATED

	 	 	 	 	 
	 	 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	JPMORGAN CHASE BANK, N.A.,

as Administrative Agent

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

 

Schedule 1

Released Subsidiaries

1. Sierra International Inc.

2. Telair International Incorporated

3. TFX Marine Incorporated

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]